Watanabe T, Kondo M, Sakai M, Akechi T: Acceptance and commitment training for reducing burnout in medical students during a clinical clerkship in psychiatry and palliative care: A pilot study. Journal of Contextual Behavioral Science 30:20-30, 2023

Watanabe T, Akechi T: The mediating role of psychological flexibility in the association of autistic-like traits with burnout and depression in medical students during clinical clerkships in Japan: a university-based cross-sectional study. BMC Psychiatry 23:302, 2023

Uno H, Hayashi W, Nakagawa A, Otowa T, Yamada H, Iwanami A. Psychosis in adults with autism spectrum disorder and attention deficit hyperactivity disorder at acute psychiatric wards. Eur J Psychiatry 2023. doi; 10.1016/j.ejpsy.2022.12.001

Uchida M, Furukawa TA, Yamaguchi T, Imai F, Momino K, Katsuki F, Sakurai N, Miyaji T, Horikoshi M, Iwata H, Zenda S, Iwatani T, Ogawa A, Inoue A, Abe M, Toyama T, Uchitomi Y, Matsuoka H, Noma H, Akechi T: Optimization of smartphone psychotherapy for depression and anxiety among patients with cancer using the multiphase optimization strategy (MOST) framework and decentralized clinical trial system (SMartphone Intervention to LEssen depression/Anxiety and GAIN resilience: SMILE AGAIN project): a protocol for a randomized controlled trial. Trials 24:344, 2023

Toyomoto R, Sakata M, Yoshida K, Luo Y, Nakagami Y, Uwatoko T, Shimamoto T, Sahker E, Tajika A, Suga H, Ito H, Sumi M, Muto T, Ito M, Ichikawa H, Ikegawa M, Shiraishi N, Watanabe T, Watkins ER, Noma H, Horikoshi M, Iwami T, Furukawa TA. Prognostic factors and effect modifiers for personalisation of internet-based cognitive behavioural therapy among university students with subthreshold depression: A secondary analysis of a factorial trial. J Affect Disord. 322:156-162 2023

Toshishige Y, Kondo M, Ito Y, Hashimoto H, Okazaki J, Okami T, Mizushima H, Akechi T: Interpersonal psychotherapy for bereavement-related major depressive disorder in Japan: a pilot study Cogent Psychology, 2023

Toshishige Y, Kondo M, Watanabe T, Yamada A, Hashimoto H, Okazaki J, Tokuyama : Association between marital satisfaction of female patients with persistent depressive disorder, and their own and husbands’ autism spectrum disorder or attention deficit/hyperactivity disorder traits Psychiatry and Clinical Neurosciences Reports, 2023

Takashina HN, Ueda S, Sakai M, Takahashi F, Sato H, Hudson JL, Rapee RM, Ishikawa SI. Randomised controlled trial of cultural-adapted and programme-adopted cognitive behavioural therapy for children and adolescents' anxiety in Japan: protocol for a Multi-, Inter-, and Cross-cultural Clinical Child Study (MIXCS). BMJ Open. 18;13(7)2023

Shiraishi N, Sakata M, Toyomoto R, Yoshida K, Luo Y, Nakagami Y, Tajika A, Suga H, Ito H, Sumi M, Muto T, Ichikawa H, Ikegawa M, Watanabe T, Sahker E, Uwatoko T, Noma H, Horikoshi M, Iwami T, Furukawa TA. Three types of university students with subthreshold depression characterized by distinctive cognitive behavioral skills. Cogn Behav Ther53：207-219：2023

Shiraishi N, Sakata M, Toyomoto R, Yoshida K, Luo Y, Nakagami Y, Tajika A, Watanabe T, Sahker E, Uwatoko T, Shimamoto T, Iwami T, Furukawa TA. Dynamics of depressive states among university students in Japan during the COVID-19 pandemic: an interrupted time series analysis. Ann Gen Psychiatry：22(1):38. 2023

Sadahiro R, Hatta K, Yamaguchi T, Masanori E, Matsuda Y, Ogawa A, Iwata Y, Tokoro A, Nakahara R, Hirayama T, Yanai Y, Ogawa Y, Kayano A, Ariyoshi K, Oyamada S, Uchitomi Y, Akechi T, Yamamoto N, Okita N, Yorikane E, Shimada K, Furukawa T, Hashimoto H, Maeda M, Sato T, Sekimoto A, Sasaki C, Saito E, Uezono Y, Matsuoka H: A multi-centre, double-blind, randomized, placebo-controlled trial to evaluate the effectiveness and safety of ramelteon for the prevention of postoperative delirium in elderly cancer patients: a study protocol for JORTC-PON2/J-SUPPORT2103/NCCH2103. Jpn J Clin Oncol 53:851-857, 2023

Okami T, Toshishige Y, Kondo M, Okazaki J, Mizushima H, Akechi T: Interpersonal psychotherapy for comorbid prolonged grief disorder and persistent depressive disorder in a Japanese patient: A case report Psychiatry and Clinical Neurosciences Reports, 2023

Obama K, Fujimori M, Okamura M, Kadowaki M, Ueno T, Boku N, Mori M, Akechi T, Yamaguchi T, Oyamada S, Okizaki A, Miyaji T, Sakurai N, Uchitomi Y: Effectiveness of a facilitation programme using a mobile application for initiating advance care planning discussions between patients with advanced cancer and healthcare providers: protocol for a randomised controlled trial (J-SUPPORT 2104). BMJ Open 13:e069557, 2023

Ninomiya K, Inoue D, Sugimoto K, Tanaka C, Murofushi K, Okuyama T, et al. Significance of the comprehensive geriatric assessment in the administration of chemotherapy to older adults with cancer: Recommendations by the Japanese Geriatric Oncology Guideline Committee. J Geriatr Oncol. 2023;14(5):101485.

Matsuda Y, Tanimukai H, Inoue S, Hirayama T, Kanno Y, Kitaura Y, et al. A revision of JPOS/JASCC clinical guidelines for delirium in adult cancer patients: a summary of recommendation statements. Jpn J Clin Oncol. 2023;53(9):808-22.

Kurisu K, Harashima S, Fujimori M, Akechi T, Yoshiuchi K, Uchitomi Y: Regional disparities in suicide among patients with cancer: A nationwide population-based study in Japan. Cancer Med 12:20052-20058, 2023

Katsuki F, Yamada A, Kondo M, Sawada H, Watanabe N, Akechi T: Association between social support for mothers of patients with eating disorders and mothers' active listening attitude: a cohort study BioPsychoSocial medicine 17: 4, 2023

Hirayama T, Fujimori M, Ito Y, Ishida Y, Tsumura A, Ozawa M, Maeda N, Yamamoto K, Takita S, Mori M, Tanaka K, Horibe K, Akechi T: Feasibility and preliminary effectiveness of a psychosocial support program for adolescent and young adult cancer patients in clinical practice: a retrospective observational study Support Care Cancer 31: 146, 2023

Hasegawa T, Okuyama T, Uemura T, Matsuda Y, Otani H, Shimizu J, Horio Y, Watanabe N, Yamaguchi T, Fukuda S, Oguri T, Maeno K, Taniguchi Y, Nosaki K, Fukumitsu K, Akechi T: Elements of End-of-Life Discussions Associated With Patients' Reported Outcomes and Actual End-of-Life Care in Patients With Pretreated Lung Cancer. Oncologist, 2023 Hasegawa T, Ito Y, Furukawa Y, Okuyama T, Kojima N, Uchida M, Tasaki Y, Suzuki N, Ishida K, Kashima S, Kubota Y, Akechi T: Specialized Palliative Care and Intensity of End-of-Life Care Among Adolescents and Young Adults with Cancer: A Medical Chart Review. J Adolesc Young Adult Oncol 12:488-495, 2023

Fuzisawa D, Akechi T, Uchitomi Y: Depressive disorders, in Kissane D, et al. (eds): Psycho-Oncology in Palliative and End of Life Care. London, Oxford University Press, 2023, pp 70-93

Furukawa TA, Tajika A, Sakata M, Luo Y, Toyomoto R, Horikoshi M, Akechi T, Kawakami N, Nakayama T, Kondo N, Fukuma S, Noma H, Christensen H, Kessler RC, Cuijpers P, Wason JMS: Four 2×2 factorial trials of smartphone CBT to reduce subthreshold depression and to prevent new depressive episodes among adults in the community-RESiLIENT trial (Resilience Enhancement with Smartphone in LIving ENvironmenTs): a master protocol BMJ Open 13: e067850, 2023

Akechi T, Yamaguchi T, Uchida M, Imai F, Momino K, Katsuki F, Sakurai N, Miyaji T, Mashiko T, Horikoshi M, Furukawa TA, Yoshimura A, Ohno S, Uehiro N, Higaki K, Hasegawa Y, Akahane K, Uchitomi Y, Iwata H: Smartphone Psychotherapy Reduces Fear of Cancer Recurrence Among Breast Cancer Survivors: A Fully Decentralized Randomized Controlled Clinical Trial (J-SUPPORT 1703 Study) J Clin Oncol 41: 1069-1078, 2023

山田敦朗：【いま,知っておきたい発達障害 Q&A 98】診断 身体科入院中で発達障害を疑われる患者さんへの対応のコツを教えてください 精神医学 65(5) 602-603 2023
山田敦朗：非定型発達を評価するための検査とその結果の解釈　―起立性調節障害の合併を疑った際の対応を含めて― 精神医学　第65巻　第6号　912-1061　2023
山田敦朗：【子どものうつ病に気づく】子どものうつ病は周囲の大人(親や教師)にどのように見えているのか 精神医学 65(7) 1007-1015 2023
利重裕子：【周産期メンタルヘルスの最先端】周産期うつ病に対する対人関係療法ー治療と予防ー精神科治療学 38(12) 1419‐1424 2023 酒井美枝：慢性痛患者に対する心理社会面の評価の実際 慢性疼痛 42(1) 19-22 2023
酒井美枝：痛みの難治化に対するアクセプタンス＆コミットメント・セラピーの視点 日本運動器疼痛学会誌 15 124-130 2023
酒井美枝, 杉浦健之, 永田富義, 青木晃大, 山本恵美子, 近藤真前：当院いたみセンターに紹介された慢性痛患者像の把握と多職種介入内容の検討 日本ペインクリニック学会誌 30(10) 241-243 2023
音羽健司．【よくわかる！精神疾患対応これ1冊　第4部 知っておきたい精神疾患 各論2：不安症・恐怖症・ストレス性疾患】限局性恐怖症．診断と治療 112 (Suppl); 155-158, 2024.
音羽 健司.【プライマリケア医に必要な情報をまるっと整理 くすりの使い方便利帳】(第9章)神経系に作用する薬剤 ベンゾジアゼピン系抗不安薬. 内科 131(4) 1024-1028 2023.
音羽 健司.【不安症再考】不安症の遺伝子研究. 精神科 42(2) 202-208 2023.
小川 晴香, 白石 直, 明智 龍男：特集 性差と精神医学 ─ なぜ頻度や重症度に差があるのか 摂食症（摂食障害）における性差 精神医学 66(1) 51-56 2024
小川 晴香, 白石 直, 明智 龍男：増大号特集 いま,知っておきたい発達障害 Q＆A 98 5 鑑別と併存 Q53 摂食障害と発達障害を合併している大人は,高齢化するほど治療が困難となるように思います。対応のコツがあれば教えてください 精神医学 65(5) 687-688 2023
名越 泰秀, 富永 敏行, 酒井 美枝, 舘野 歩：身体症状症の治療戦略―難治例へのテーラーメイド治療― 精神神経学雑誌 125(12) 1010-1022 2023
松平 浩, 笠原諭, 酒井美枝, 井上真輔, 鉄永倫子, 高橋紀代, 高槻梢, 二瓶健司, 矢吹省司, 髙橋直人：慢性疼痛患者に対する標準化を目指した集学的治療のための新心理社会的フラッグシステム 日本運動器疼痛学会誌 15 114-123 2023
松平浩, 笠原諭, 酒井美枝, 井上真輔, 鉄永倫子, 高橋紀代, 高槻梢, 二瓶健司, 矢吹省司, 髙橋直人：慢性腰痛に対する集学的治療のための 新心理社会的フラッグシステム Journal of Spine Research 14 858-868 2023
明智龍男.市川太祐.: 電子カルテビッグデータのAI解析による入院高齢患者の転倒転落の予測. 臨床精神薬理 26:293-298, 2023
明智龍男編著:「こころ」や「精神」を医学する「精神医学」とは何か？, 中外医学社, 2023
明智龍男: うつ・不眠などの心理的反応に対する支持薬, in 戸井雅和 (ed): 乳癌薬物療法の要点と盲点, 文光堂, 2023, pp 285-287
明智龍男: 抑うつ状態の患者に鎮静・安楽死を提供することは許容されるのか？サイコオンココロジーの立場から, in 森田達也／田代志門編著 (ed): 鎮静と安楽死のグレーゾーンを問う-医学・看護学・生命倫理学・法学の視点, 中外医学社, 2023
明智龍男: ストレスが関連する病気：うつ病, in 名古屋市立大学編 (ed): 名市大ブックス13　ストレスとは？あなたの生き方のヒント, 中日新聞社, 2023
明智龍男: がんなど身体疾患に関するとらわれ・こだわりの臨床と対応 精神科治療学 38: 175-181, 2023
明智龍男: がん患者の精神医学的問題, in 福井次矢., 高木誠., 小室一成. (eds): 今日の治療指針. 東京, 医学書院, 2023, pp 1067-1069

Toshishige Y, Kondo M, Okazaki J, Mizushima H, Akechi T: Interpersonal Psychotherapy for Bereavement-Related Major Depressive Disorder in Japan: A Systematic Case Report Case reports in psychiatry 2022: 9921103, 2022

Takeuchi E, Kato M, Akechi T: Bereavement care provision and its associated factors among nurses in cancer care settings: a cross-sectional study Support Care Cancer, 2022

Takabatake S, Takahashi M, Kabaya K, Sekiya Y, Sekiya K, Harata I, Kondo M, Akechi T: Validation of the Tinnitus Acceptance Questionnaire: Japanese Version Audiology research 12: 66-76, 2022

Suzuki N, Okuyama T, Akechi T, Kusumoto S, Ri M, Inagaki A, Kayukawa S, Yano H, Yoshida T, Shiraga K, Hashimoto H, Aiki S, Iida S: Symptoms and health-related quality of life in patients with newly diagnosed multiple myeloma: a multicenter prospective cohort study Jpn J Clin Oncol 52: 163-169, 2022

Sakai M, Kondo M, Sugiura T, Akechi T: Acceptance and commitment therapy in the transdiagnostic treatment of breast cancer survivor: a case study Jpn Psychol Res, 2022

Matsuoka A, Fujimori M, Narikazu B, Takashima A, Okusaka T, Mori K, Akechi T, Shimazu T, Okizaki A, Miyaji T, Majima Y, Nagashima F, Uchitomi Y: Geriatric assessment and management with question prompt list using a web-based application for elderly patients with cancer (MAPLE) to communicate ageing-related concerns: J-SUPPORT 2101 study protocol for a multicentre, parallel group, randomised controlled trial BMJ Open 12: e063445, 2022

Kurisu K, Inada S, Maeda I, Ogawa A, Iwase S, Akechi T, Morita T, Oyamada S, Yamaguchi T, Imai K, Nakahara R, Kaneishi K, Nakajima N, Sumitani M, Yoshiuchi K: A decision tree prediction model for a short-term outcome of delirium in patients with advanced cancer receiving pharmacological interventions: A secondary analysis of a multicenter and prospective observational study (Phase-R) Palliat Support Care 20: 153-158, 2022

Kurisu K, Hashimoto M, Ishizawa T, Shibayama O, Inada S, Fujisawa D, Inoguchi H, Shimoda H, Inoue S, Ogawa A, Akechi T, Shimizu K, Uchitomi Y, Matsuyama Y, Yoshiuchi K: Development of computer adaptive testing for measuring depression in patients with cancer Scientific reports 12: 8247, 2022

Kurisu K, Fujimori M, Harashima S, Akechi T, Matsuda T, Saika K, Yoshiuchi K, Miyashiro I, Uchitomi Y: Suicide, other externally caused injuries, and cardiovascular disease within 2 years after cancer diagnosis: A nationwide population-based study in Japan (J-SUPPORT 1902) Cancer Med, 2022

Ishida K, Sato K, Komatsu H, Morita T, Akechi T, Uchida M, Masukawa K, Igarashi N, Kizawa Y, Tsuneto S, Shima Y, Miyashita M, Ando S: Nationwide survey on family caregiver-perceived experiences of patients with cancer of unknown primary site Support Care Cancer, 2022

Hasegawa T, Yamagishi A, Sugishita A, Akechi T, Kubota Y, Shimoyama S: Integrating home palliative care in oncology: a qualitative study to identify barriers and facilitators Support Care Cancer, 2022

Hasegawa T, Okuyama T, Uemura T, Matsuda Y, Otani H, Shimizu J, Horio Y, Watanabe N, Yamaguchi T, Fukuda S, Oguri T, Maeno K, Tamiya A, Nosaki K, Fukumitsu K, Akechi T: Prognostic Awareness and Discussions of Incurability in Patients with Pretreated Non-Small Cell Lung Cancer and Caregivers: A Prospective Cohort Study The oncologist 27: 982-990, 2022

Hasegawa T, Ito Y, Furukawa Y, Okuyama T, Kojima N, Uchida M, Tasaki Y, Suzuki N, Ishida K, Kashima S, Kubota Y, Akechi T: Specialized Palliative Care and Intensity of End-of-Life Care Among Adolescents and Young Adults with Cancer: A Medical Chart Review Journal of adolescent and young adult oncology, 2022

Azuma H, Akechi T: EEG correlates of quality of life and associations with seizure without awareness and depression in patients with epilepsy Neuropsychopharmacology reports 42: 333-342, 2022

Aoyama M, Miyashita M, Masukawa K, Morita T, Kizawa Y, Tsuneto S, Shima Y, Akechi T: Factors related to suicidal ideation among bereaved family members of patients with cancer: Results from a nationwide bereavement survey in Japan J Affect Disord 316: 91-98, 2022

Akechi T, Yamaguchi T, Uchida M, Imai F, Momino K, Katsuki F, Sakurai N, Miyaji T, Mashiko T, Horikoshi M, Furukawa TA, Yoshimura A, Ohno S, Uehiro N, Higaki K, Hasegawa Y, Akahane K, Uchitomi Y, Iwata H: Smartphone Psychotherapy Reduces Fear of Cancer Recurrence Among Breast Cancer Survivors: A Fully Decentralized Randomized Controlled Clinical Trial (J-SUPPORT 1703 Study) J Clin Oncol: Jco2200699, 2022

Akechi T, Mishiro I, Fujimoto S: Risk of major depressive disorder in adolescent and young adult cancer patients in Japan Psychooncology, 2022

Akechi T, Kubota Y, Ohtake Y, Setou N, Fujimori M, Takeuchi E, Kurata A, Okamura M, Hasuo H, Sakamoto R, Miyamoto S, Asai M, Shinozaki K, Onishi H, Shinomiya T, Okuyama T, Sakaguchi Y, Matsuoka H: Clinical practice guidelines for the care of psychologically distressed bereaved families who have lost members to physical illness including cancer Jpn J Clin Oncol, 2022

明智龍男: 精神面のケア 最新臨床肺癌学　診断・治療の最新動向 80巻: 642-647, 2022
明智龍男: チームで行う頭頸部癌診療の多職種連携-精神腫瘍科医の立場から JOHNS 38: 1589-1592, 2022
明智龍男: リエゾン・コンサルテーション. In: 三村将 (ed) 日本医師会雑誌　精神疾患診療. 日本医師会, 東京, pp. 336-337, 2022
明智龍男: Prolonged Grief Disorderの診断基準（DSM-5-TR）. In: 一般社団法人日本サイコオンコロジー学会、一般社団法人日本がんサポーティブケア学会 (ed) 遺族ケアガイドライン-がん等の身体疾患によって重要他者を失った遺族が経験する精神心理的苦痛の診療とケアに関するガイドライン. 金原出版, 東京, pp. 119-120, 2022
明智龍男: 一般的な薬物療法、特に向精神薬の使い方について. In: 一般社団法人日本サイコオンコロジー学会、一般社団法人日本がんサポーティブケア学会 (ed) 遺族ケアガイドライン-がん等の身体疾患によって重要他者を失った遺族が経験する精神心理的苦痛の診療とケアに関するガイドライン. 金原出版, 東京, pp. 91-92, 2022
明智龍男: 精神心理的苦痛の強い遺族の診断、治療に関する現在の問題点. In: 一般社団法人日本サイコオンコロジー学会、一般社団法人日本がんサポーティブケア学会 (ed) 遺族ケアガイドライン-がん等の身体疾患によって重要他者を失った遺族が経験する精神心理的苦痛の診療とケアに関するガイドライン. 金原出版, 東京, pp. 48, 2022
明智龍男: サイコオンコロジー. In: 斉藤正彦 (ed) 講座　精神疾患の臨床　地域精神医療・リエゾン精神医療・精神科救急医療. 中山書店, 東京, pp. 232-242, 2022

Yamada A, Katsuki F, Kondo M, Sawada H, Watanabe N, Akechi T: Association between the social support for mothers of patients with eating disorders, maternal mental health, and patient symptomatic severity: A cross-sectional study Journal of eating disorders 2021; 9: 8.

Watanabe T, Kondo M, Sakai M, Takabatake S, Furukawa TA, Akechi T: Association of Autism Spectrum Disorder and Attention Deficit Hyperactivity Disorder Traits with Depression and Empathy Among Medical Students Advances in medical education and practice 2021; 12: 1259-1265.

Uemoto Y, Uchida M, Kondo N, Wanifuchi-Endo Y, Fujita T, Asano T, Hisada T, Nishikawa S, Katagiri Y, Terada M, Kato A, Okuda K, Sugiura H, Osaga S, Akechi T, Toyama T: Predictive factors for patients who need treatment for chronic post-surgical pain (CPSP) after breast cancer surgery Breast cancer (Tokyo, Japan) 2021; 28: 1346-1357.

Uchida M, Akechi T, Morita T, Shima Y, Igarashi N, Miyashita M: Development and validation of the Terminal Delirium-Related Distress Scale to assess irreversible terminal delirium Palliat Support Care 2021; 19: 287-293.

Toshishige Y, Kondo M, Akechi T: Interpersonal psychotherapy for complex posttraumatic stress disorder related to childhood physical and emotional abuse with great severity of depression: A case report Asia-Pacific psychiatry : official journal of the Pacific Rim College of Psychiatrists 2021: e12504.

Sato H, Nakaaki S, Sato J, Shikimoto R, Furukawa TA, Mimura M, Akechi T: Caregiver self-efficacy and associated factors among caregivers of patients with dementia with Lewy bodies and caregivers of patients with Alzheimer's disease Psychogeriatrics 2021; 21: 783-794.

Maeda I, Inoue S, Uemura K, Tanimukai H, Hatano Y, Yokomichi N, Amano K, Tagami K, Yoshiuchi K, Ogawa A, Iwase S: Low-Dose Trazodone for Delirium in Patients with Cancer Who Received Specialist Palliative Care: A Multicenter Prospective Study J Palliat Med 2021; 24: 914-918.

Kumagai N, Tajika A, Hasegawa A, Kawanishi N, Fujita H, Tsujino N, Jinnin R, Uchida M, Okamoto Y, Akechi T, Furukawa TA: Assessing recurrence of depression using a zero-inflated negative binomial model: A secondary analysis of lifelog data Psychiatry Res 2021; 300: 113919.

Inoue K, Kawashima Y, Noguchi H, Fujimori M, Akechi T, Kawanishi C, Uchitomi Y, Matsuoka YJ: Attitude to suicide prevention and suicide intervention skills among oncology professionals: An online cross-sectional survey in Japan Psychiatry Clin Neurosci 2021;

Hasegawa T, Akechi T, Osaga S, Tsuji T, Okuyama T, Sakurai H, Masukawa K, Morita T, Kizawa Y, Tsuneto S, Shima Y, Miyashita M: Unmet need for palliative rehabilitation in inpatient hospices/palliative care units: a nationwide post-bereavement survey Jpn J Clin Oncol 2021; 51: 1334-1338.

Harashima S, Fujimori M, Akechi T, Matsuda T, Saika K, Hasegawa T, Inoue K, Yoshiuchi K, Miyashiro I, Uchitomi Y, Y JM: Death by suicide, other externally caused injuries and cardiovascular diseases within 6 months of cancer diagnosis (J-SUPPORT 1902) Jpn J Clin Oncol 2021; 51: 744-752.

Carey ML, Uchida M, Zucca AC, Okuyama T, Akechi T, Sanson-Fisher RW: Experiences of Patient-Centered Care Among Japanese and Australian Cancer Outpatients: Results of a Cross-Sectional Study Journal of patient experience 2021; 8: 23743735211007690.

Aoyama M, Miyashita M, Masukawa K, Morita T, Kizawa Y, Tsuneto S, Shima Y, Akechi T: Predicting models of depression or complicated grief among bereaved family members of patients with cancer Psychooncology 2021; 30: 1151-1159.

Aogi K, Takeuchi H, Saeki T, Aiba K, Tamura K, Iino K, Imamura CK, Okita K, Kagami Y, Tanaka R, Nakagawa K, Fujii H, Boku N, Wada M, Akechi T, Iihara H, Ohtani S, Okuyama A, Ozawa K, Kim YI, Sasaki H, Shima Y, Takeda M, Nagasaki E, Nishidate T, Higashi T, Hirata K: Optimizing antiemetic treatment for chemotherapy-induced nausea and vomiting in Japan: Update summary of the 2015  Japan Society of Clinical Oncology Clinical Practice Guidelines for Antiemesis Int J Clin Oncol 2021; 26: 1-17.

Akechi T, Momino K, Katsuki F, Yamashita H, Sugiura H, Yoshimoto N, Wanifuchi-Endo Y, Toyama T: Brief collaborative care intervention to reduce perceived unmet needs in highly distressed breast cancer patients: randomized controlled trial Jpn J Clin Oncol 2021; 51: 244-251.

明智龍男., 杉浦建之., 編著.: こころとからだにチームでのぞむ　慢性疼痛ケースブック. 医学書院, 東京, 2021
明智龍男: スマートフォンを用いた精神療法とICT技術を駆使した革新的臨床試験システムの開発. : 西智弘., 矢野和美., 柏木秀行. (編) 緩和ケアに活かすICT. 青海社, 東京, pp. 59-63, 2021
明智龍男: サイコオンコロジー. In: 日本臨床腫瘍学会 (編) 新臨床腫瘍学改訂第6版-がん薬物療法専門医のために. 南江堂, 東京, pp. 355-360, 2021
長谷川貴昭, 明智龍男: データでみる日本の緩和ケア主体の時期のリハビリテーション-遺族調査からの示唆. I日本ホスピス•緩和ケア研究振興財団 (編) ホスピス緩和ケア白書2021, pp. 47-53, 2021
酒井美枝., 明智龍男.: 長引く痛みへの新対処法-痛みのある人生を、自分らしく、しなやかに生きる. In: 名古屋市立大学 (編) 名市大ブックス6　支えあう人生のための医療. 中日新聞社, 名古屋市, pp. 6-15, 2021
明智龍男.: 「実感と納得」に向けた病気と治療の伝え方　コンサルテーションリエゾンおよびサイコオンコロジー 精神医学 2021; 63: 1713-1719.
明智龍男: こころの中に安易に踏み込んではいけないこともある-死にゆく患者の「否認」をケアすることの大切さ Medical Practice 2021; 38: 1918.
明智龍男: 終末期がん患者の緩和ケア 臨床精神医学 2021; 50: 823-828.
明智龍男: 身体疾患にみられる抑うつ状態の評価 臨床精神薬理 2021; 24: 831-837.
明智龍男: 担がん患者をみるための標準的知識と技能 精神科治療学 2021; 36: 177-181.
明智龍男: 「死にたい」に関する精神医学的評価-合理的な死の希望はあるか？ 緩和かケア 2021; 31: 182-186.
近藤真前．【めまい・ふらつき - QOL向上をめざした診療 -】めまいを生じる機能性疾患・精神疾患．ENTONI 2021;256:38-45

Akechi T: Optimal goal of management of delirium in end-of-life cancer care. Lancet Oncol 2020, 21(7):872-873.

Akechi T: Suicide prevention among patients with cancer. Gen Hosp Psychiatry 2020, 64:119-120.

Akechi T, Fujimoto S, Mishiro I, Murase K: Treatment of Major Depressive Disorder in Japanese Patients with Cancer: A Matched Cohort Study Using Employer-Based Health Insurance Claims Data. Clin Drug Investig 2020, 40(12):1115-1125.

Akechi T, Mishiro I, Fujimoto S, Murase K: Risk of major depressive disorder in Japanese cancer patients: A matched cohort study using employer-based health insurance claims data. Psychooncology 2020, 29(10):1686-1694.

Akechi T, Mishiro I, Fujimoto S, Murase K: Risk of major depressive disorder in spouses of cancer patients in Japan: A cohort study using health insurance-based claims data. Psychooncology 2020, 29(7):1224-1227.

Akechi T, Momino K, Katsuki F, Yamashita H, Sugiura H, Yoshimoto N, Wanifuchi-Endo Y, Toyama T: Brief collaborative care intervention to reduce perceived unmet needs in highly distressed breast cancer patients: randomized controlled trial. Jpn J Clin Oncol 2020.

Akechi T, Okuyama T, Uchida M, Kubota Y, Hasegawa T, Suzuki N, Komatsu H, Kusumoto S, Iida S: Factors associated with suicidal ideation in patients with multiple myeloma. Jpn J Clin Oncol 2020, 50(12):1475-1478.

Akechi T, Sugishita K, Chino B, Itoh K, Ikeda Y, Shimodera S, Yonemoto N, Miki K, Ogawa Y, Takeshima N et al: Whose depression deteriorates during acute phase antidepressant treatment? J Affect Disord 2020, 260:342-348.

Aogi K, Takeuchi H, Saeki T, Aiba K, Tamura K, Iino K, Imamura CK, Okita K, Kagami Y, Tanaka R et al: Optimizing antiemetic treatment for chemotherapy-induced nausea and vomiting in Japan: Update summary of the 2015 Japan Society of Clinical Oncology Clinical Practice Guidelines for Antiemesis. Int J Clin Oncol 2020.

Azuma H, Ogawa H, Suzuki E, Akechi T: Intraclass correlations of seizure duration by wavelet transform, sample entropy, and visual determination in electroconvulsive therapy.Neuropsychopharmacol Rep 2020, 40(1):102-106.

Funada S, Watanabe N, Goto T, Negoro H, Akamatsu S, Ueno K, Uozumi R, Ichioka K, Segawa T, Akechi T et al: Cognitive behavioral therapy for overactive bladder in women: study protocol for a randomized controlled trial. BMC Urol 2020, 20(1):129.

Furukawa TA, Debray TPA, Akechi T, Yamada M, Kato T, Seo M, Efthimiou O: Corrigendum to "Can personalized treatment prediction improve the outcomes, compared with the group average approach, in a randomized trial? Developing and validating a multivariable prediction model in a pragmatic megatrial of acute treatment for major depression". [Journal of Affective Disorders 274 (2020) 690-697]. J Affect Disord 2020, 276:1174-1175.

Furukawa TA, Debray TPA, Akechi T, Yamada M, Kato T, Seo M, Efthimiou O: Can personalized treatment prediction improve the outcomes, compared with the group average approach, in a randomized trial? Developing and validating a multivariable prediction model in a pragmatic megatrial of acute treatment for major depression. J Affect Disord 2020, 274:690-697.

Hasegawa T, Sekine R, Akechi T, Osaga S, Tsuji T, Okuyama T, Sakurai H, Masukawa K, Aoyama M, Morita T et al: Rehabilitation for Cancer Patients in Inpatient Hospices/Palliative Care Units and Achievement of a Good Death: Analyses of Combined Data From Nationwide Surveys Among Bereaved Family Members. J Pain Symptom Manage 2020, 60(6):1163-1169.

Imai K, Morita T, Akechi T, Baba M, Yamaguchi T, Sumi H, Tashiro S, Aita K, Shimizu T, Hamano J et al: The Principles of Revised Clinical Guidelines about Palliative Sedation Therapy of the Japanese Society for Palliative Medicine. J Palliat Med 2020, 23(9):1184-1190.

Kabaya K, Kondo M, Naganuma H, Nakamura Y, Mihara T, Umibe A, Sato T, Imai T, Suzuki K, Ishii M et al: Disability in Protracted Benign Paroxysmal Positional Vertigo at One Month from Symptom Onset- a Questionnaire Survey. Journal of Otology & Rhinology 2020, 9(7).

Katsuki F, Yamada A, Kondo M, Sawada H, Watanabe N, Akechi T, Paola R: Development and validation of the 10-item Social Provisions Scale (SPS-10) Japanese version. Nagoya Medical Journal 2020.

Kuwabara J, Kondo M, Kabaya K, Watanabe W, Shiraishi N, Sakai M, Toshishige Y, Ino K, Nakayama M, Iwasaki S et al: Acceptance and commitment therapy combined with vestibular rehabilitation for persistent postural-perceptual dizziness: A pilot study. Am J Otolaryngol 2020, 41(6):102609.

Maeda I, Ogawa A, Yoshiuchi K, Akechi T, Morita T, Oyamada S, Yamaguchi T, Imai K, Sakashita A, Matsumoto Y et al: Safety and effectiveness of antipsychotic medication for delirium in patients with advanced cancer: A large-scale multicenter prospective observational study in real-world palliative care settings. Gen Hosp Psychiatry 2020, 67:35-41.

Matsuda Y, Maeda I, Morita T, Yamauchi T, Sakashita A, Watanabe H, Kaneishi K, Amano K, Iwase S, Ogawa A et al: Reversibility of delirium in Ill-hospitalized cancer patients: Does underlying etiology matter? Cancer Med 2020, 9(1):19-26.

Matsuda Y, Tanimukai H, Inoue S, Inada S, Sugano K, Hasuo H, Yoshimura M, Wada S, Dotani C, Adachi H et al: JPOS/JASCC clinical guidelines for delirium in adult cancer patients: a summary of recommendation statements. Jpn J Clin Oncol 2020, 50(5):586-593.

Nakayama M, Hori H, Itoh M, Lin M, Niwa M, Ino K, Imai R, Ogawa S, Sekiguchi A, Matsui M et al: Possible Long-Term Effects of Childhood Maltreatment on Cognitive Function in Adult Women With Posttraumatic Stress Disorder. Front Psychiatry 2020, 11:344.

Ogawa S, Imai R, Suzuki M, Furukawa TA, Akechi T: The Relationship between Symptoms and Social Functioning over the Course of Cognitive Behavioral Therapy for Social Anxiety Disorder. Psychiatry J 2020, 2020:3186450.

Otsuka T, Hori H, Yoshida F, Itoh M, Lin M, Niwa M, Ino K, Imai R, Ogawa S, Matsui M et al: Association of CRP genetic variation with symptomatology, cognitive function, and circulating proinflammatory markers in civilian women with PTSD. J Affect Disord 2021, 279:640-649.

Shiraishi N, Reilly J: Content analysis of the emotions affecting caregivers of relatives with schizophrenia. Current Psychology 2020.

Toshishige Y, Kondo M, Kabaya K, Watanabe W, Fukui A, Kuwabara J, Nakayama M, Iwasaki S, Furukawa TA, Akechi T: Cognitive-behavioural therapy for chronic subjective dizziness: Predictors of improvement in Dizziness Handicap Inventory at 6 months posttreatment. Acta Otolaryngol 2020, 140(10):827-832.

Tsumura A, Okuyama T, Ito Y, Kondo M, Saitoh S, Kamei M, Sato I, Ishida Y, Kato Y, Takeda Y et al: Reliability and validity of a Japanese version of the psychosocial assessment tool for families of children with cancer. Jpn J Clin Oncol 2020, 50(3):296-302.

Uchida M, Morita T, Akechi T, Yokomichi N, Sakashita A, Hisanaga T, Matsui T, Ogawa A, Yoshiuchi K, Iwase S et al: Are common delirium assessment tools appropriate for evaluating delirium at the end of life in cancer patients? Psychooncology 2020, 29(11):1842-1849.

Yamada T, Nakaaki S, Sato J, Sato H, Shikimoto R, Furukawa TA, Mimura M, Akechi T: Factor structure of the Japanese version of the Quality of Life in Alzheimer's Disease Scale (QOL-AD). Psychogeriatrics 2020, 20(1):79-86.

井上 真, 谷向 仁, 松田 能, 足立 浩, 稲田 修, 岡本 禎, 菅野 康, 堂谷 知, 蓮尾 英, 吉村 匡 et al: 【研究の観点からみた症例報告】せん妄の臨床研究からみた症例報告. 精神科 2020, 37(2):185-191.

奥山 徹: 【悩ましい局面で薬をどう使う?せん妄薬物療法のリスク・ベネフィット】疾患・病態別のせん妄薬物療法　低活動型せん妄. 薬事 2020, 62(8):1547-1550.
奥山徹: せん妄. In: がん診療における精神症状・心理状態・発達障害ハンドブック. edn. Edited by 小山敦子: 羊土社; 2020: 14-33.
奥山徹: せん妄に伴う認知機能への影響. In: がんと認知機能障害. edn. Edited by 谷向仁:中外医学社; 2020: 73-85.
明智龍男: 進行がん患者の自殺対策. In: がん医療における自殺対策の手引き（2019年版）https://www.ncc.go.jp/jp/ncch/division/icsppc/index.html edn. Edited by 国立がん研究センター編. 令和元年度革新的自殺研究推進プログラム委託研究 がん患者の専門的・精神心理的なケアと支援方法に関する研究 2020: 41-47.
明智龍男: せん妄ケアのエッセンス-中でも低活動型に焦点をあてて. 東京: 医学書院; 2020.
明智龍男: 身体疾患による精神障害. In: 今日の治療指針. edn. Edited by 福井次矢., 高木誠., 小室一成. 東京: 医学書院; 2020: 1051-1052.
明智龍男: 最初の抗うつ薬で十分に反応が得られなかったとき、どうすべきか？SUND臨床試験のStepIIの概要と結果の紹介. 精神医学 2020, 62(1):25-30.
明智龍男: 「がん患者におけるせん妄ガイドライン」2019年のポイント解説. 日本薬剤師会雑誌 2020, 72(12):11-15.
明智龍男: 総合病院精神医学の人材育成. 精神医学 2020, 62(3):277-282.
近藤真前: 【SUN-D臨床試験のインパクト-日本初の医師主導型抗うつ薬大規模臨床試験から学ぶ】SUN-D臨床試験に参加して行った工夫　名古屋市立大学病院から. 精神医学 2020, 62(1):51.

Akechi T, Sugishita K, Chino B, Itoh K, Ikeda Y, Shimodera S, Yonemoto N, Miki K, Ogawa Y, Takeshima N, Kato T, Furukawa TA: Whose depression deteriorates during acute phase antidepressant treatment? J Affect Disord 2020; 260: 342-348.

Yamada T, Nakaaki S, Sato J, Sato H, Shikimoto R, Furukawa TA, Mimura M, Akechi T: Factor structure of the Japanese version of the Quality of Life in Alzheimer's Disease Scale (QOL-AD) Psychogeriatrics 2019;

Uchida M, Sugie C, Yoshimura M, Suzuki E, Shibamoto Y, Hiraoka M, Akechi T: Factors associated with a preference for disclosure of life expectancy information from physicians: a cross-sectional survey of cancer patients undergoing radiation therapy Support Care Cancer 2019;

Uchida M, Morita T, Ito Y, Koga K, Akechi T: Goals of care and treatment in terminal delirium: A qualitative study of the views and experiences of healthcare professionals caring for patients with cancer Palliat Support Care 2019; 17: 403-408.

Tsumura A, Okuyama T, Ito Y, Kondo M, Saitoh S, Kamei M, Sato I, Ishida Y, Kato Y, Takeda Y, Akechi T: Reliability and validity of a Japanese version of the psychosocial assessment tool for families of children with cancer Jpn J Clin Oncol 2019;

Shiraishi N, Watanabe N, Katsuki F, Sakaguchi H, Akechi T: Effectiveness of the Japanese standard family psychoeducation on the mental health of caregivers of young adults with schizophrenia: a randomised controlled trial BMC Psychiatry 2019; 19: 263.

Sanagawa A, Shiraishi N, Sekiguchi F, Akechi T, Kimura K: Successful Use of Brexpiprazole for Parkinson's Disease Psychosis Without Adverse Effects: A Case Report J Clin Psychopharmacol 2019;

Onishi H, Ishida M, Uchida N, Takahashi T, Furuya D, Ebihara Y, Sato I, Akechi T: Thiamine deficiency observed in a cancer patient's caregiver Palliat Support Care 2019: 1-3.

Okuyama T, Yoshiuchi K, Ogawa A, Iwase S, Yokomichi N, Sakashita A, Tagami K, Uemura K, Nakahara R, Akechi T: Current Pharmacotherapy Does Not Improve Severity of Hypoactive Delirium in Patients with Advanced Cancer: Pharmacological Audit Study of Safety and Efficacy in Real World (Phase-R) The oncologist 2019; 24: e574-e582.

Nishioka M, Okuyama T, Uchida M, Aiki S, Ito Y, Osaga S, Imai F, Akechi T: What is the appropriate communication style for family members confronting difficult surrogate decision-making in palliative care?: A randomized video vignette study in medical staff with working experiences of clinical oncology Jpn J Clin Oncol 2019; 49: 48-56.

Imai R, Hori H, Itoh M, Lin M, Niwa M, Ino K, Ogawa S, Sekiguchi A, Kunugi H, Akechi T, Kamo T, Kim Y: Relationships of blood proinflammatory markers with psychological resilience and quality of life in civilian women with posttraumatic stress disorder Scientific reports 2019; 9: 17905.

Imai F, Momino K, Katsuki F, Horikoshi M, Furukawa TA, Kondo N, Toyama T, Yamaguchi T, Akechi T: Smartphone problem-solving therapy to reduce fear of cancer recurrence among breast cancer survivors: an open single-arm pilot study Jpn J Clin Oncol 2019; 49: 537-544.

Hasegawa T, Okuyama T, Uchida M, Aiki S, Imai F, Nishioka M, Suzuki N, Iida S, Komatsu H, Kusumoto S, Ri M, Osaga S, Akechi T: Depressive symptoms during the first month of chemotherapy and survival in patients with hematological malignancies: A prospective cohort study Psychooncology 2019;

Harashima S, Fujimori M, Akechi T, Matsuda T, Saika K, Hasegawa T, Inoue K, Yoshiuchi K, Miyashiro I, Uchitomi Y, Matsuoka YJ: Suicide, other externally caused injuries and cardiovascular death following a cancer diagnosis: study protocol for a nationwide population-based study in Japan (J-SUPPORT 1902) BMJ Open 2019; 9: e030681.

Azuma H, Ogawa H, Suzuki E, Akechi T: Intraclass correlations of seizure duration by wavelet transform, sample entropy, and visual determination in electroconvulsive therapy Neuropsychopharmacology reports 2019;

Akechi T, Mantani A, Kurata K, Hirota S, Shimodera S, Yamada M, Inagaki M, Watanabe N, Kato T, Furukawa TA: Predicting relapse in major depression after successful initial pharmacological treatment J Affect Disord 2019; 250: 108-113.

Akechi T, Kato T, Watanabe N, Tanaka S, Furukawa TA: Predictors of hypomanic and/or manic switch among patients initially diagnosed with unipolar major depression during acute-phase antidepressants treatment Psychiatry Clin Neurosci 2019; 73: 90-91.

Akechi T, Kato T, Fujise N, Yonemoto N, Tajika A, Furukawa TA: Why some depressive patients perform suicidal acts and others do not Psychiatry Clin Neurosci 2019;

Akechi T: Suicide prevention among patients with cancer Gen Hosp Psychiatry 2019

明智龍男: 総合病院精神医学の人材育成 精神医学 62: 277-282, 2020
明智龍男: 最初の抗うつ薬で十分に反応が得られなかったとき、どうすべきか？SUND臨床試験のStepIIの概要と結果の紹介 精神医学 62: 25-30, 2020
明智龍男: 身体疾患をもつ方の不安抑うつのケアと精神疾患をもつ方ががんになったときのケア 日本精神保健看護学会誌 28: 92-103, 2019
明智龍男: 死にゆくプロセスにおける実存的苦痛への対応 医学のあゆみ 271: 1232-1233, 2019
明智龍男: からだとこころはひとつながり Medical Practice 36: 1652-1657, 2019
明智龍男: ガイドライン　ココだけおさえる　がん患者におけるせん妄ガイドライン2019年版 日本医事新報 4983: 36-39, 2019
明智龍男: 身体疾患による精神障害. 福井次矢, 高木誠, 小室一成. (編) 今日の治療指針. 医学書院, 東京, pp. 1051-1052, 2020
明智龍男: 精神症状. 勝俣範之 (編) 月刊薬事7月増刊号　逸脱症例から学ぶがん薬物療法　標準治療の実践, 東京, pp. 168-171, 2019
明智龍男: がん患者の精神医学的問題. 福井次矢, 高木誠, 小室一成. (編) 今日の治療指針. 医学書院, 東京, pp. 1064-1065, 2019
近藤真前: 超高齢化社会における認知療法・認知行動療法による寄与の可能性. 認知行動療法とアクセプタンス＆コミットメント・セラピーは身体症状を有する高齢患者にどのように貢献できるか？ 認知療法研究 12(1): 10-16, 2019
酒井美枝, 明智龍男: 進行・終末期がん患者に対する認知行動療法 認知療法研究 12: 17-21, 2019
高畠聡, 近藤 真前: マインドフルネス療法は他の精神療法と何が違うのか？アクセプタンス&コミットメント・セラピー(ACT)からみたマインドフルネス　精神医学61(6): 655-662, 2019
長谷川貴昭, 奧山徹, 明智龍男: がん医療におけるアドバンス・ケア・プランニング-最新の知見と今後の課題 癌と化学療法 46: 609-616, 2019
山田敦朗: 大人の発達障害の怒りへの対応 精神医学　61(11): 1287-96, 2019

Aiki, S., T. Okuyama, K. Sugano, Y. Kubota, F. Imai, M. Nishioka, Y. Ito, S. Iida, H. Komatsu, T. Ishida, S. Kusumoto, and T. Akechi, Cognitive dysfunction among newly diagnosed older patients with hematological malignancy: frequency, clinical indicators and predictors. Jpn J Clin Oncol, 2018. 48(1): p. 61-67.

Akechi, T., T. Okuyama, J. Onishi, T. Morita, and T.A. Furukawa, WITHDRAWN: Psychotherapy for depression among incurable cancer patients. Cochrane Database Syst Rev, 2018. 11: p. CD005537.

Akechi, T., T. Yamaguchi, M. Uchida, F. Imai, K. Momino, F. Katsuki, N. Sakurai, T. Miyaji, M. Horikoshi, T.A. Furukawa, H. Iwata, and Y. Uchitomi, Smartphone problem-solving and behavioural activation therapy to reduce fear of recurrence among patients with breast cancer (SMartphone Intervention to LEssen fear of cancer recurrence: SMILE project): protocol for a randomised controlled trial. BMJ Open, 2018. 8(11): p. e024794.

Furukawa, T.A., M. Horikoshi, H. Fujita, N. Tsujino, R. Jinnin, Y. Kako, S. Ogawa, H. Sato, N. Kitagawa, Y. Shinagawa, Y. Ikeda, H. Imai, A. Tajika, Y. Ogawa, T. Akechi, M. Yamada, S. Shimodera, N. Watanabe, M. Inagaki, and A. Hasegawa, Cognitive and Behavioral Skills Exercises Completed by Patients with Major Depression During Smartphone Cognitive Behavioral Therapy: Secondary Analysis of a Randomized Controlled Trial. JMIR Ment Health, 2018. 5(1): p. e4.

Furukawa, T.A., H. Imai, M. Horikoshi, S. Shimodera, T. Hiroe, T. Funayama, T. Akechi, and F. Investigators, Behavioral activation: Is it the expectation or achievement, of mastery or pleasure that contributes to improvement in depression? J Affect Disord, 2018. 238: p. 336-341.

Furukawa, T.A., T. Kato, T. Akechi, S. Shimodera, N. Okada, I. Yanai, K. Ozaki, and K. Kinou, Dropouts in an Antidepressant Trial: How Do They Fare Afterwards? Psychother Psychosom, 2018. 87(6): p. 380-382.

Hasegawa, T., T. Oguri, T. Osawa, T. Sawa, S. Osaga, T. Okuyama, M. Uchida, K. Maeno, S. Fukuda, H. Nishie, A. Niimi, and T. Akechi, Opioid Dose and Survival of Patients with Incurable Nonsmall Cell Lung Cancer: A Prospective Cohort Study. J Palliat Med, 2018. 21(10): p. 1436-1441.

Imai, R., H. Hori, M. Itoh, M. Lin, M. Niwa, K. Ino, S. Ogawa, M. Ishida, A. Sekiguchi, M. Matsui, H. Kunugi, T. Akechi, T. Kamo, and Y. Kim, Inflammatory markers and their possible effects on cognitive function in women with posttraumatic stress disorder. J Psychiatr Res, 2018. 102: p. 192-200.

Kato, T., T.A. Furukawa, A. Mantani, K. Kurata, H. Kubouchi, S. Hirota, H. Sato, K. Sugishita, B. Chino, K. Itoh, Y. Ikeda, Y. Shinagawa, M. Kondo, Y. Okamoto, H. Fujita, M. Suga, S. Yasumoto, N. Tsujino, T. Inoue, N. Fujise, T. Akechi, M. Yamada, S. Shimodera, N. Watanabe, M. Inagaki, K. Miki, Y. Ogawa, N. Takeshima, Y. Hayasaka, A. Tajika, K. Shinohara, N. Yonemoto, S. Tanaka, Q. Zhou, G.H. Guyatt, and S. Investigators, Optimising first- and second-line treatment strategies for untreated major depressive disorder - the SUND study: a pragmatic, multi-centre, assessor-blinded randomised controlled trial. BMC Med, 2018. 16(1): p. 103.

Katsuki, F., H. Takeuchi, T. Inagaki, T. Maeda, Y. Kubota, N. Shiraishi, H. Tabuse, T. Kato, A. Yamada, N. Watanabe, T. Akechi, and T.A. Furukawa, Brief multifamily Psychoeducation for family members of patients with chronic major depression: a randomized controlled trial. BMC Psychiatry, 2018. 18(1): p. 207.

Kubota, Y., T. Akechi, and T. Okuyama, Effectiveness of a brief psycho-oncology training program for general nurses: a preliminary study. Jpn J Clin Oncol, 2018. 48(6): p. 594-597.

Ogawa, A., K. Kondo, H. Takei, D. Fujisawa, Y. Ohe, and T. Akechi, Decision-Making Capacity for Chemotherapy and Associated Factors in Newly Diagnosed Patients with Lung Cancer. Oncologist, 2018. 23(4): p. 489-495.

Ogawa, S., M. Kondo, K. Ino, R. Imai, T. Ii, T.A. Furukawa, and T. Akechi, Predictors of Broad Dimensions of Psychopathology among Patients with Panic Disorder after Cognitive-Behavioral Therapy. Psychiatry J, 2018. 2018: p. 5183834.

Sugiyama, Y., T. Kataoka, Y. Tasaki, Y. Kondo, N. Sato, T. Naiki, N. Sakamoto, T. Akechi, and K. Kimura, Efficacy of tapentadol for first-line opioid-resistant neuropathic pain in Japan. Jpn J Clin Oncol, 2018. 48(4): p. 362-366.

明智龍男 Psychiatric Lecture　治療　死にゆく患者に対する新たなアプローチ　ディグニティセラピー. 精神科臨床Legato, 2018. 4(1): p. 25-27.
明智龍男【エンド・オブ・ライフ・ケアの精神医学】終末期がん患者へのアプローチ. 精神科, 2018. 32(2): p. 123-127.
明智龍男　がん医療におけるこころの医学　精神腫瘍学から精神病理学への期待を含めて. 臨床精神病理, 2018. 39(1): p. 3-9.
明智龍男【サイコオンコロジー】サイコオンコロジーの重要性　現状と今後の展望. 精神医学, 2018. 60(5): p. 447-454.
明智龍男. 問題解決療法. In: 吉内一浩., editor. 行動医学・心身医学アプローチ. 東京: 医歯薬出版株式会社; 2018. p. 58-63.
明智龍男. せん妄に対する緩和ケア. In: 日本緩和医療学会ガイドライン総括委員会 特, editor. がん患者の治療抵抗性の苦痛と鎮静に関する基本的な考え方の手引き. 東京: 金原出版; 2018. p. 34-42.
明智龍男. がん患者に頻度の高い精神症状. In: 日本産婦人科医会, editor. 研修ノート（No 101）　婦人科がん医療の近未来. 東京: 日本産婦人科医会; 2018. p. 92-3.
明智龍男. サイコオンコロジー. In: 日本臨床腫瘍学会, editor. 新臨床腫瘍学改訂第5版-がん薬物療法専門医のために. 東京: 南江堂; 2018. p. 385-90.
明智龍男. コンサルテーション・リエゾン精神医学. In: 尾崎紀夫, 三村將, 水野雅文, 村井俊哉, editors. 標準精神医学第7版. 東京: 医学書院; 2018. p. 181-93.
明智龍男. 認知行動療法. In: 福井次矢., 高木誠., 小室一成., editors. 今日の治療指針. 東京: 医学書院; 2018. p. 998-9.
内田恵, 明智龍男, 森田達也, 木澤義之, 奥山徹, 木下寛也, 松本禎久, がん患者の苦痛に関するスクリーニング・トリアージプログラムを普及するためのワークショップの有用性. Palliative Care Research, 2018. 13(3): p. 273-279.
奥山徹　がん患者におけるせん妄マネージメント. 新薬と臨牀, 2018. 67(9): p. 1108-1115.
近藤真前　【治療抵抗性抑うつに対し外来診療でできること】一般外来におけるうつ病に対する対人関係療法. 2018. 120(5): 408-415.
酒井美枝, 近藤真前, 杉浦健之　アクセプタンス & コミットメント・セラピーに基づく心理的介入を実施した大後頭三叉神経痛症候群の一症例

Akechi, T., Aiki, S., Sugano, K., Uchida, M., Yamada, A., Komatsu, H., Ishida, T., Kusumoto, S., Iida, S. and Okuyama, T. Does cognitive decline decrease health utility value in older adult patients with cancer? Psychogeriatrics 17(3):149-154, 2017

Akechi, T., Suzuki, M., Hashimoto, N., Yamada, T., Yamada, A. and Nakaaki, S. Different pharmacological responses in late-life depression with subsequent dementia: a case supporting the reserve threshold theory. Psychogeriatrics 17(6):500-501, 2017

Fujimori, M., Akechi, T. and Uchitomi, Y. Factors associated with patient preferences for communication of bad news. Palliat Support Care 15(3):328-335, 2017

Ino, K., Ogawa, S., Kondo, M., Imai, R., Ii, T., Furukawa, T. A. and Akechi, T. Anxiety sensitivity as a predictor of broad dimensions of psychopathology after cognitive behavioral therapy for panic disorder. Neuropsychiatr Dis Treat 13(1835-1840, 2017

Momino, K., Mitsunori, M., Yamashita, H., Toyama, T., Sugiura, H., Yoshimoto, N., Hirai, K. and Akechi, T. Collaborative care intervention for the perceived care needs of women with breast cancer undergoing adjuvant therapy after surgery: a feasibility study. Jpn J Clin Oncol 47(3):213-220, 2017

Ogawa, A., Kondo, K., Takei, H., Fujisawa, D., Ohe, Y. and Akechi, T. Decision-Making Capacity for Chemotherapy and Associated Factors in Newly Diagnosed Patients with Lung Cancer. Oncologist, 2017

Ogawa, S., Imai, R., Suzuki, M., Furukawa, T. A. and Akechi, T. The Mechanisms Underlying Changes in Broad Dimensions of Psychopathology During Cognitive Behavioral Therapy for Social Anxiety Disorder. J Clin Med Res 9(12):1019-1021, 2017

Ogawa, S., Kondo, M., Ino, K., Ii, T., Imai, R., Furukawa, T. A. and Akechi, T. Fear of Fear and Broad Dimensions of Psychopathology over the Course of Cognitive Behavioural Therapy for Panic Disorder with Agoraphobia in Japan. East Asian Arch Psychiatry 27(4):150-5, 2017

Ogawa, S., Kondo, M., Okazaki, J., Imai, R., Ino, K., Furukawa, T. A. and Akechi, T. The relationships between symptoms and quality of life over the course of cognitive-behavioral therapy for panic disorder in Japan. Asia Pac Psychiatry 9(2), 2017

Okuyama, T., Akechi, T., Mackenzie, L. and Furukawa, T. A. Psychotherapy for depression among advanced, incurable cancer patients: A systematic review and meta-analysis. Cancer Treat Rev 56(16-27, 2017

Onishi, H., Ishida, M., Tanahashi, I., Takahashi, T., Taji, Y., Ikebuchi, K., Furuya, D. and Akechi, T. Subclinical thiamine deficiency in patients with abdominal cancer. Palliat Support Care:1-3, 2017

Onishi, H., Ishida, M., Tanahashi, I., Takahashi, T., Taji, Y., Ikebuchi, K., Furuya, D. and Akechi, T. Wernicke encephalopathy without delirium in patients with cancer. Palliat Support Care 16(1):118-121, 2018

Sakamoto, N., Takiguchi, S., Komatsu, H., Okuyama, T., Nakaguchi, T., Kubota, Y., Ito, Y., Sugano, K., Wada, M. and Akechi, T. Supportive care needs and psychological distress and/or quality of life in ambulatory advanced colorectal cancer patients receiving chemotherapy: a cross-sectional study. Jpn J Clin Oncol 47(12):1157-1161, 2017

明智龍男: せん妄、手術後精神障害（ICU）症候群. Journal/今日の治療指針 993, 2017
明智龍男: 適応障害. Journal/婦人科がん領域における緩和医療の実践 158-165, 2017
明智龍男: リスペリドン少量で傾眠と誤嚥性肺炎発生. Journal/苦い経験から学ぶ！緩和医療ピットフォールファイル 72, 2017
明智龍男: 「本人が不安を感じています」は本当？. Journal/苦い経験から学ぶ！緩和医療ピットフォールファイル 136-137, 2017
明智龍男. チーム医療において心理職が知っておく基礎知識. 精神療法 43(6):527-831, 2017
明智龍男. 高齢発症の適応障害. 精神科治療学 32(増刊号):350-353, 2017
明智龍男. がん患者の不安・うつと自殺. 精神科 31(4):286-289, 2017
明智龍男. 死にゆく患者に対して私たちはなにができるのだろうか？. 老年精神医学雑誌 28(8):830-831, 2017
明智龍男. がん患者の精神症状の特徴とその評価. 薬局 68(6):51-54, 2017
明智龍男. がん患者にはどのように接すればよいのでしょうか. medicina 54(8):1204-1207, 2017
明智龍男. がん患者・家族へのbad newsの伝え方. 血液内科 74(4):557-561, 2017
明智龍男. 乳癌診療を支える医療-サイコオンコロジー. 乳癌学 75(suppl 3):434-437, 2017
明智龍男. なぜせん妄は防ぐことがむずかしいのか. Modern Physician 37(4):329-332, 2017
明智龍男. がん患者の不安・抑うつ・せん妄とがん性疼痛に対する精神医学的アプローチ. 臨床精神薬理 20(4):429-436, 2017
今井必生, 古川壽亮, 堀越勝, 渡辺範雄, 明智龍男, 川西直 and 長谷川晃朗. スマートフォンを用いた認知行動療法. 精神科 30(5):431-435, 2017
近藤真前 and 渡辺範雄. 認知行動療法をはじめとする精神療法の使い分け―症例から考える―慢性痛に対する認知行動療法・その他の精神療法のエビデンス. 精神科治療学 32(7):869-873, 2017
近藤真前. マインドフルネス―精神科治療への導入と展開―アクセプタンス＆コミットメント・セラピーにおけるマインドフルネス. 精神科治療学 32(5):605-608, 2017
藤澤大介, 鈴木伸一, 大江悠樹, 近藤真前, 中野有美 and 平井啓. 身体疾患領域における認知行動療法のひろがり. 認知療法研究 10(2):106-116, 2017
山田敦朗. 発達障害における治療と育ち. 臨床精神病理 38(236-241, 2017

Akechi, T., S. Aiki, K. Sugano, M. Uchida, A. Yamada, H. Komatsu, T. Ishida, S. Kusumoto, S. Iida, and T. Okuyama, Does cognitive decline decrease health utility value in older adult patients with cancer? Psychogeriatrics, 2016.

Akechi, T., K. Momino, and H. Iwata, Author reply: Brief screening of breast cancer survivors with distressing fear of recurrence. Breast Cancer Res Treat, 2016. 156(1): p. 205-6.

Akizuki, N., K. Shimizu, M. Asai, T. Nakano, T. Okusaka, K. Shimada, H. Inoguchi, M. Inagaki, M. Fujimori, T. Akechi, and Y. Uchitomi, Prevalence and predictive factors of depression and anxiety in patients with pancreatic cancer: a longitudinal study. Jpn J Clin Oncol, 2016. 46(1): p. 71-7.

Fujimori, M., T. Akechi, and Y. Uchitomi, Factors associated with patient preferences for communication of bad news. Palliat Support Care, 2016: p. 1-8.

Fujisawa, D., H. Inoguchi, H. Shimoda, K. Yoshiuchi, S. Inoue, A. Ogawa, T. Okuyama, T. Akechi, M. Mimura, K. Shimizu, and Y. Uchitomi, Impact of depression on health utility value in cancer patients. Psychooncology, 2016. 25(5): p. 491-5.

Inoguchi, H., K. Shimizu, H. Shimoda, K. Yoshiuchi, T. Akechi, M. Uchida, A. Ogawa, D. Fujisawa, S. Inoue, and Y. Uchitomi, Screening for untreated depression in cancer patients: a Japanese experience. Jpn J Clin Oncol, 2016.

Ishida, K., S. Ando, H. Komatsu, S. Kinoshita, Y. Mori, and T. Akechi, Psychological burden on patients with cancer of unknown primary: from onset of symptoms to initial treatment. Jpn J Clin Oncol, 2016. 46(7): p. 652-60.

Kawaguchi, A., K. Nemoto, S. Nakaaki, T. Kawaguchi, H. Kan, N. Arai, N. Shiraishi, N. Hashimoto, and T. Akechi, Insular Volume Reduction in Patients with Social Anxiety Disorder. Front Psychiatry, 2016. 7: p. 3.

Kubota, Y., T. Okuyama, M. Uchida, S. Umezawa, T. Nakaguchi, K. Sugano, Y. Ito, F. Katsuki, Y. Nakano, T. Nishiyama, Y. Katayama, and T. Akechi, Effectiveness of a psycho-oncology training program for oncology nurses: a randomized controlled trial. Psychooncology, 2016. 25(6): p. 712-8.

Ogawa, S., M. Kondo, J. Okazaki, R. Imai, K. Ino, T.A. Furukawa, and T. Akechi, The relationships between symptoms and quality of life over the course of cognitive-behavioral therapy for panic disorder in Japan. Asia Pac Psychiatry, 2016.

Okuyama, T., Y. Kizawa, T. Morita, H. Kinoshita, M. Uchida, A. Shimada, A.S. Naito, and T. Akechi, Current Status of Distress Screening in Designated Cancer Hospitals: A Cross-Sectional Nationwide Survey in Japan. J Natl Compr Canc Netw, 2016. 14(9): p. 1098-104.

Onishi, H., M. Ishida, H. Toyama, I. Tanahashi, K. Ikebuchi, Y. Taji, K. Fujiwara, and T. Akechi, Early detection and successful treatment of Wernicke encephalopathy in a patient with advanced carcinoma of the external genitalia during chemotherapy. Palliat Support Care, 2016. 14(3): p. 302-6.

Sugiyama, Y., N. Sakamoto, M. Ohsawa, M. Onizuka, K. Ishida, Y. Murata, A. Iio, K. Sugano, K. Maeno, H. Takeyama, T. Akechi, and K. Kimura, A Retrospective Study on the Effectiveness of Switching to Oral Methadone for Relieving Severe Cancer-Related Neuropathic Pain and Limiting Adjuvant Analgesic Use in Japan. J Palliat Med, 2016. 19(10): p. 1051-1059.

Takeuchi, H., T. Saeki, K. Aiba, K. Tamura, K. Aogi, K. Eguchi, K. Okita, Y. Kagami, R. Tanaka, K. Nakagawa, H. Fujii, N. Boku, M. Wada, T. Akechi, Y. Udagawa, Y. Okawa, Y. Onozawa, H. Sasaki, Y. Shima, N. Shimoyama, M. Takeda, T. Nishidate, A. Yamamoto, T. Ikeda, and K. Hirata, Japanese Society of Clinical Oncology clinical practice guidelines 2010 for antiemesis in oncology: executive summary. Int J Clin Oncol, 2016. 21(1): p. 1-12.

Yamada, A., N. Miyachi, T. Miura, M. Suzuki, N. Watanabe, and T. Akechi, Long-term poor rapport, lack of spontaneity and passive social withdrawal related to acute post-infectious encephalitis: a case report. Springerplus, 2016. 5: p. 345.

Yamauchi, T., M. Inagaki, N. Yonemoto, M. Iwasaki, T. Akechi, N. Sawada, H. Iso, M. Noda, S. Tsugane, and J.S. Group, History of diabetes and risk of suicide and accidental death in Japan: The Japan Public Health Centre-based Prospective Study, 1990-2012. Diabetes Metab, 2016. 42(3): p. 184-91.

Akechi T, Uchida M, Nakaguchi T, Okuyama T, Sakamoto N, Toyama T, Yamashita H.Difference of patient's perceived need in breast cancer patients after diagnosis. Jpn J Clin Oncol. 2015 Jan;45(1):75-80.

Akechi T, Furukawa TA.Depressed with cancer can respond to antidepressants, but further research is needed to confirm and expand on these findings. Evid Based Ment Health. 2015 Feb;18(1):28.

Akechi T, Momino K, Iwata H.　Brief screening of patients with distressing fear of recurrence in breast cancer survivors. Breast Cancer Res Treat. 2015 Sep;153(2):475-6.

Akechi T, Momino K, Miyashita M, Sakamoto N, Yamashita H, Toyama T.
Anxiety in disease-free breast cancer patients might be alleviated by provision of psychological support, not of information. Jpn J Clin Oncol. 2015 Oct;45(10):929-33.

Ito Y, Okuyama T, Ito Y, Kamei M, Nakaguchi T, Sugano K, Kubota Y, Sakamoto N, Saitoh S,Akechi T. Good death for children with cancer: a qualitative study.
Jpn J Clin Oncol. 2015 Apr;45(4):349-55.

Kondo M, Kiyomizu K, Goto F, Kitahara T, Imai T, Hashimoto M, Shimogori H, Ikezono T, Nakayama M, Watanabe N, Akechi T. Analysis of vestibular-balance symptoms according to symptom duration: dimensionality of the Vertigo Symptom Scale-short form. Health Qual Life Outcomes. 2015 Jan 22;13:4.

Okuyama T, Sugano K, Iida S, Ishida T, Kusumoto S, Akechi T. Screening Performance for Frailty Among Older Patients With Cancer: A Cross-Sectional Observational Study of Two Approaches. J Natl Compr Canc Netw. 2015 Dec;13(12):1525-31.

Onishi H, Ishida M, Toyama H, Tanahashi I, Ikebuchi K, Taji Y, Fujiwara K, Akechi T. Early detection and successful treatment of Wernicke encephalopathy in a patient with advanced carcinoma of the external genitalia during chemotherapy. Palliat Support Care. 2015 Dec 11:1-5.

Shimizu K, Nakaya N, Saito-Nakaya K, Akechi T, Ogawa A, Fujisawa D, Sone T, Yoshiuchi K, Goto K, Iwasaki M, Tsugane S, Uchitomi Y. Personality traits and coping styles explain anxiety in lung cancer patients to a greater extent than other factors. Jpn J Clin Oncol. 2015 May;45(5):456-63.

Sugano K, Okuyama T, Iida S, Komatsu H, Ishida T, Kusumoto S, Uchida M, Nakaguchi T, Kubota Y, Ito Y, Takahashi K, Akechi T. Medical Decision-Making Incapacity among Newly Diagnosed Older Patients with Hematological Malignancy Receiving First Line Chemotherapy: A Cross-Sectional Study of Patients and Physicians. PLoS One. 2015 Aug 21;10(8):e0136163.

Uchida M, Okuyama T, Ito Y, Nakaguchi T, Miyazaki M, Sakamoto M, Kamiya T, Sato S, Takeyama H, Joh T, Meagher D, Akechi T. Prevalence, course and factors associated with delirium in elderly patients with advanced cancer: a longitudinal observational study. Jpn J Clin Oncol. 2015 Oct;45(10):934-40.

Wada S, Shimizu K, Inoguchi H, Shimoda H, Yoshiuchi K, Akechi T, Uchida M, Ogawa A, Fujisawa D, Inoue S, Uchitomi Y, Matsushima E. The Association Between Depressive Symptoms and Age in Cancer Patients: A Multicenter Cross-Sectional Study. J Pain Symptom Manage. 2015 Dec;50(6):768-77.

Watanabe N, Horikoshi M, Yamada M, Shimodera S, Akechi T, Miki K, Inagaki M, Yonemoto N, Imai H, Tajika A, Ogawa Y, Takeshima N, Hayasaka Y, Furukawa TA; Steering Committee of the Fun to Learn to Act and Think through Technology Project. Adding smartphone-based cognitive-behavior therapy to pharmacotherapy for major depression (FLATT project): study protocol for a randomized controlled trial.Trials. 2015 Jul 7;16:293.

Yonemoto N, Tanaka S, Furukawa TA, Kato T, Mantani A, Ogawa Y, Tajika A, Takeshima N, Hayasaka Y, Shinohara K, Miki K, Inagaki M, Shimodera S, Akechi T, Yamada M, Watanabe N, Guyatt GH; SUN(^_^)D Investigators.
Strategic use of new generation antidepressants for depression: SUN(^_^) D protocol update and statistical analysis plan. Trials. 2015 Oct 14;16:459.

Akechi, T., K. Momino, T. Yamashita, T. Fujita, H. Hayashi, N. Tsunoda, and H. Iwata, Contribution of problem-solving skills to fear of recurrence in breast cancer survivors. Breast Cancer Res Treat, 2014. 145(1): p. 205-10.

Azuma, H. and T. Akechi, Effects of psychosocial functioning, depression, seizure frequency, and employment on quality of life in patients with epilepsy. Epilepsy Behav, 2014. 41: p. 18-20.

Banno, K., S. Nakaaki, J. Sato, K. Torii, J. Narumoto, J. Miyata, N. Hirono, T.A. Furukawa, M. Mimura, and T. Akechi, Neural basis of three dimensions of agitated behaviors in patients with Alzheimer disease. Neuropsychiatr Dis Treat, 2014. 10: p. 339-48.

Hashimoto, N., S. Nakaaki, A. Kawaguchi, J. Sato, H. Kasai, T. Nakamae, J. Narumoto, J. Miyata, T.A. Furukawa, and M. Mimura, Brain structural abnormalities in behavior therapy-resistant obsessive-compulsive disorder revealed by voxel-based morphometry. Neuropsychiatr Dis Treat, 2014. 10: p. 1987-96.

Katsuki, F., H. Takeuchi, N. Watanabe, N. Shiraishi, T. Maeda, Y. Kubota, M. Suzuki, A. Yamada, and T. Akechi, Multifamily psychoeducation for improvement of mental health among relatives of patients with major depressive disorder lasting more than one year: study protocol for a randomized controlled trial. Trials, 2014. 15: p. 320.

Kawaguchi, A, S. Nakaaki, T. Kawaguchi, N. Hashimoto, S. Ogawa, M. Suzuki, T. Ii, K. Sugano, T. Akechi, Hippocampal volume increased after cognitive behavioral therapy in a patient with social anxiety disorder: A case report. J Neuropsychiatry Clin Neurosci. Volume 26 Issue 4, Fall 2014, pp. E4-E5

Matsuoka, T., Y. Kato, S. Taniguchi, M. Ogawa, H. Fujimoto, A. Okamura, K. Shibata, K. Nakamura, H. Uchida, S. Nakaaki, H. Koumi, M. Mimura, K. Fukui, and J. Narumoto, Japanese versions of the executive interview (J-EXIT25) and the executive clock drawing task (J-CLOX) for older people. Int Psychogeriatr, 2014. 26(8): p. 1387-97.

Momino, K., T. Akechi, T. Yamashita, T. Fujita, H. Hayahi, N. Tsunoda, M. Miyashita, and H. Iwata, Psychometric properties of the Japanese version of the Concerns About Recurrence Scale (CARS-J). Jpn J Clin Oncol, 2014. 44(5): p. 456-62.

Morita, T., M. Kuriya, M. Miyashita, K. Sato, K. Eguchi, and T. Akechi, Symptom burden and achievement of good death of elderly cancer patients. J Palliat Med, 2014. 17(8): p. 887-93.

Nakanotani, T., T. Akechi, T. Takayama, A. Karato, Y. Kikuuchi, N. Okamoto, K. Katayama, M. Yokoo, and A. Ogawa, Characteristics of elderly cancer patients' concerns and their quality of life in Japan: a Web-based survey. Jpn J Clin Oncol, 2014. 44(5): p. 448-55.

Shibayama, O., K. Yoshiuchi, M. Inagaki, Y. Matsuoka, E. Yoshikawa, Y. Sugawara, T. Akechi, N. Wada, S. Imoto, K. Murakami, A. Ogawa, A. Akabayashi, and Y. Uchitomi, Association between adjuvant regional radiotherapy and cognitive function in breast cancer patients treated with conservation therapy. Cancer Med, 2014. 3(3): p. 702-9.

Shiraishi, N., A. Nishida, S. Shimodera, T. Sasaki, N. Oshima, N. Watanabe, T. Akechi, T.A. Furukawa, and Y. Okazaki, Relationship between violent behavior and repeated weight-loss dieting among female adolescents in Japan. PLoS One, 2014. 9(9): p. e107744.

Shiraishi, N., N. Watanabe, Y. Kinoshita, A. Kaneko, S. Yoshida, T.A. Furukawa, and T. Akechi, Brief psychoeducation for schizophrenia primarily intended to change the cognition of auditory hallucinations: an exploratory study. J Nerv Ment Dis, 2014. 202(1): p. 35-9.

Suzuki, M., A. Yamada, N. Watanabe, T. Akechi, F. Katsuki, T. Nishiyama, M. Imaeda, T. Miyachi, K. Otaki, Y. Mitsuda, A. Ota, and T.A. Furukawa, A failure to confirm the effectiveness of a brief group psychoeducational program for mothers of children with high-functioning pervasive developmental disorders: a randomized controlled pilot trial. Neuropsychiatr Dis Treat, 2014. 10: p. 1141-53.

Yamauchi, T., M. Inagaki, N. Yonemoto, M. Iwasaki, M. Inoue, T. Akechi, H. Iso, S. Tsugane, and J.S. Group, Death by suicide and other externally caused injuries after stroke in Japan (1990-2010): the Japan Public Health Center-based prospective study. Psychosom Med, 2014. 76(6): p. 452-9.

Yamauchi, T., M. Inagaki, N. Yonemoto, M. Iwasaki, M. Inoue, T. Akechi, H. Iso, S. Tsugane, and J.S. Group, Death by suicide and other externally caused injuries following a cancer diagnosis: the Japan Public Health Center-based Prospective Study. Psychooncology, 2014. 23(9): p. 1034-41.

Yokoo, M., T. Akechi, T. Takayama, A. Karato, Y. Kikuuchi, N. Okamoto, K. Katayama, T. Nakanotani, and A. Ogawa, Comprehensive assessment of cancer patients' concerns and the association with quality of life. Jpn J Clin Oncol, 2014. 44(7): p. 670-6.

Akechi, T., T. Okuyama, M. Uchida, K. Sugano, Y. Kubota, Y. Ito, N. Sakamoto, and Y. Kizawa, Assessing medical decision making capacity among cancer patients: Preliminary clinical experience of using a competency assessment instrument. Palliat Support Care, 2013: p. 1-5.

Asai, M., N. Akizuki, M. Fujimori, K. Shimizu, A. Ogawa, Y. Matsui, T. Akechi, K. Itoh, M. Ikeda, R. Hayashi, T. Kinoshita, A. Ohtsu, K. Nagai, H. Kinoshita, and Y. Uchitomi, Impaired mental health among the bereaved spouses of cancer patients. Psychooncology, 2013. 22(5): p. 995-1001.

Fielding, R., W.W. Lam, S.C. Shun, T. Okuyama, Y.H. Lai, M. Wada, T. Akechi, W.W. Li, and N. for Asia-Pacific Psycho-Oncology, Attributing variance in supportive care needs during cancer: culture-service, and individual differences, before clinical factors. PLoS One, 2013. 8(5): p. e65099.

Furukawa, T.A., Y. Nakano, T. Funayama, S. Ogawa, T. Ietsugu, Y. Noda, J. Chen, N. Watanabe, and T. Akechi, Cognitive-behavioral therapy modifies the naturalistic course of social anxiety disorder: findings from an ABA design study in routine clinical practices. Psychiatry Clin Neurosci, 2013. 67(3): p. 139-47.

Inagaki, M., T. Akechi, T. Okuyama, Y. Sugawara, H. Kinoshita, Y. Shima, K. Terao, S. Mitsunaga, A. Ochiai, and Y. Uchitomi, Associations of interleukin-6 with vegetative but not affective depressive symptoms in terminally ill cancer patients. Support Care Cancer, 2013. 21(8): p. 2097-106.

Kawaguchi, A., S. Nakaaki, T. Kawaguchi, and T. Akechi, A case of schizophrenia accompanied by lissencephaly. J Neuropsychiatry Clin Neurosci, 2013. 25(4): p. E17-8.

Kawaguchi, A., N. Watanabe, Y. Nakano, S. Ogawa, M. Suzuki, M. Kondo, T.A. Furukawa, and T. Akechi, Group cognitive behavioral therapy for patients with generalized social anxiety disorder in Japan: outcomes at 1-year follow up and outcome predictors. Neuropsychiatr Dis Treat, 2013. 9: p. 267-75.

Morokuma, I., S. Shimodera, H. Fujita, H. Hashizume, N. Kamimura, A. Kawamura, A. Nishida, T.A. Furukawa, and S. Inoue, Psychoeducation for major depressive disorders: a randomised controlled trial. Psychiatry Res, 2013. 210(1): p. 134-9.

Nakaaki, S., J. Sato, K. Torii, T. Kawaguchi, A. Kawaguchi, J. Narumoto, and M. Mimura, Reduction in white matter before and after the development of delusions of theft in a patient with Alzheimer disease. J Neuropsychiatry Clin Neurosci, 2013. 25(4): p. E15-6.

Nakaaki, S., J. Sato, K. Torii, T. Kawaguchi, A. Kawaguchi, J. Narumoto, and M. Mimura, Neuroanatomical abnormalities before the onset of various types of delusions in a patient with Alzheimer disease. J Neuropsychiatry Clin Neurosci, 2013. 25(3): p. E65-6.

Nakaaki, S., J. Sato, K. Torii, M. Oka, A. Negi, T. Nakamae, J. Narumoto, J. Miyata, T.A. Furukawa, and M. Mimura, Neuroanatomical abnormalities before onset of delusions in patients with Alzheimer's disease: a voxel-based morphometry study. Neuropsychiatr Dis Treat, 2013. 9: p. 1-8.

Nakaaki, S., J. Sato, K. Torii, M. Oka, A. Negi, T. Nakamae, J. Narumoto, J. Miyata, T.A. Furukawa, and M. Mimura, Decreased white matter integrity before the onset of delusions in patients with Alzheimer's disease: diffusion tensor imaging. Neuropsychiatr Dis Treat, 2013. 9: p. 25-9.

Nakaguchi, T., T. Okuyama, M. Uchida, Y. Ito, H. Komatsu, M. Wada, and T. Akechi, Oncology nurses' recognition of supportive care needs and symptoms of their patients undergoing chemotherapy. Jpn J Clin Oncol, 2013. 43(4): p. 369-76.

Nakano, Y., T. Akechi, T.A. Furukawa, and M. Sugiura-Ogasawara, Cognitive behavior therapy for psychological distress in patients with recurrent miscarriage. Psychol Res Behav Manag, 2013. 6: p. 37-43.

Sato, J., S. Nakaaki, K. Torii, M. Oka, A. Negi, H. Tatsumi, J. Narumoto, T.A. Furukawa, and M. Mimura, Behavior management approach for agitated behavior in Japanese patients with dementia: a pilot study. Neuropsychiatr Dis Treat, 2013. 9: p. 9-14.

Snyder, C.F., A.L. Blackford, T. Okuyama, T. Akechi, H. Yamashita, T. Toyama, M.A. Carducci, and A.W. Wu, Using the EORTC-QLQ-C30 in clinical practice for patient management: identifying scores requiring a clinician's attention. Qual Life Res, 2013. 22(10): p. 2685-91.

Sugiura-Ogasawara, M., Y. Nakano, Y. Ozaki, and T.A. Furukawa, Possible improvement of depression after systematic examination and explanation of live birth rates among women with recurrent miscarriage. J Obstet Gynaecol, 2013. 33(2): p. 171-4.

Watanabe, N., T.A. Furukawa, S. Shimodera, F. Katsuki, H. Fujita, M. Sasaki, Y. Suga, K. Kakeda, and M.L. Perlis, Can assessors in a psychotherapy trial be successfully blinded? Analysis of a randomized controlled trial on psychotherapy for refractory insomnia in residual depression. Psychother Psychosom, 2013. 82(6): p. 401-3.

Akechi, T., Psychotherapy for depression among patients with advanced cancer. Jpn J Clin Oncol, 2012. 42(12): p. 1113-9.

Akechi, T., T. Akazawa, Y. Komori, T. Morita, H. Otani, T. Shinjo, T. Okuyama, and M. Kobayashi, Dignity therapy: Preliminary cross-cultural findings regarding implementation among Japanese advanced cancer patients. Palliat Med, 2012. 26(5): p. 768-9.

Akechi, T., M. Miyashita, T. Morita, T. Okuyama, M. Sakamoto, R. Sagawa, and Y. Uchitomi, Good death in elderly adults with cancer in Japan based on perspectives of the general population. J Am Geriatr Soc, 2012. 60(2): p. 271-6.

Akechi, T., T. Okuyama, M. Uchida, T. Nakaguchi, Y. Ito, H. Yamashita, T. Toyama, H. Komatsu, Y. Kizawa, and M. Wada, Perceived needs, psychological distress and quality of life of elderly cancer patients. Jpn J Clin Oncol, 2012. 42(8): p. 704-10.

Akechi, T., T. Okuyama, M. Uchida, T. Nakaguchi, K. Sugano, Y. Kubota, Y. Ito, Y. Kizawa, and H. Komatsu, Clinical indicators of depression among ambulatory cancer patients undergoing chemotherapy. Jpn J Clin Oncol, 2012. 42(12): p. 1175-80.

Ando, M., T. Morita, T. Akechi, and K. Takashi, Factors in narratives to questions in the short-term life review interviews of terminally ill cancer patients and utility of the questions. Palliat Support Care, 2012: p. 1-8.

Asai, M., N. Akizuki, M. Fujimori, K. Shimizu, A. Ogawa, Y. Matsui, T. Akechi, K. Itoh, M. Ikeda, R. Hayashi, T. Kinoshita, A. Ohtsu, K. Nagai, H. Kinoshita, and Y. Uchitomi, Impaired mental health among the bereaved spouses of cancer patients. Psychooncology, 2012.

Cipriani, A., M. Purgato, T.A. Furukawa, C. Trespidi, G. Imperadore, A. Signoretti, R. Churchill, N. Watanabe, and C. Barbui, Citalopram versus other anti-depressive agents for depression. Cochrane Database Syst Rev, 2012. 7: p. CD006534.

Hirai, K., H. Motooka, N. Ito, N. Wada, A. Yoshizaki, M. Shiozaki, K. Momino, T. Okuyama, and T. Akechi, Problem-solving therapy for psychological distress in Japanese early-stage breast cancer patients. Jpn J Clin Oncol, 2012. 42(12): p. 1168-74.

Kinoshita, K., Y. Kinoshita, S. Shimodera, A. Nishida, K. Inoue, N. Watanabe, N. Oshima, T. Akechi, T. Sasaki, S. Inoue, T.A. Furukawa, and Y. Okazaki, Not only body weight perception but also body mass index is relevant to suicidal ideation and self-harming behavior in Japanese adolescents. J Nerv Ment Dis, 2012. 200(4): p. 305-9.

Kishi, Y., M. Kato, T. Okuyama, and S. Thurber, Treatment of delirium with risperidone in cancer patients. Psychiatry Clin Neurosci, 2012. 66(5): p. 411-7.

Shimizu, K., N. Nakaya, K. Saito-Nakaya, T. Akechi, Y. Yamada, M. Fujimori, A. Ogawa, D. Fujisawa, K. Goto, M. Iwasaki, S. Tsugane, and Y. Uchitomi, Clinical biopsychosocial risk factors for depression in lung cancer patients: a comprehensive analysis using data from the Lung Cancer Database Project. Ann Oncol, 2012. 23(8): p. 1973-9.

Shimodera, S., T. Kato, H. Sato, K. Miki, Y. Shinagawa, M. Kondo, H. Fujita, I. Morokuma, Y. Ikeda, T. Akechi, N. Watanabe, M. Yamada, M. Inagaki, N. Yonemoto, T.A. Furukawa, and S. Investigators, The first 100 patients in the SUN(^_^)D trial (strategic use of new generation antidepressants for depression): examination of feasibility and adherence during the pilot phase. Trials, 2012. 13: p. 80.

Watanabe, N., A. Nishida, S. Shimodera, K. Inoue, N. Oshima, T. Sasaki, S. Inoue, T. Akechi, T.A. Furukawa, and Y. Okazaki, Help-seeking behavior among Japanese school students who self-harm: results from a self-report survey of 18,104 adolescents. Neuropsychiatr Dis Treat, 2012. 8: p. 561-9.

Watanabe, N., A. Nishida, S. Shimodera, K. Inoue, N. Oshima, T. Sasaki, S. Inoue, T. Akechi, T.A. Furukawa, and Y. Okazaki, Deliberate self-harm in adolescents aged 12-18: a cross-sectional survey of 18,104 students. Suicide Life Threat Behav, 2012. 42(5): p. 550-60.

Yamada, A., M. Kato, M. Suzuki, M. Suzuki, N. Watanabe, T. Akechi, and T.A. Furukawa, Quality of life of parents raising children with pervasive developmental disorders. BMC Psychiatry, 2012. 12: p. 119.

Akechi, T., T. Okuyama, C. Endo, R. Sagawa, M. Uchida, T. Nakaguchi, T. Akazawa, H. Yamashita, T. Toyama, and T.A. Furukawa, Patient's perceived need and psychological distress and/or quality of life in ambulatory breast cancer patients in Japan. Psychooncology, 2011. 20(5): p. 497-505.

Akechi, T., T. Okuyama, R. Sagawa, M. Uchida, T. Nakaguchi, Y. Ito, and T.A. Furukawa, Social anxiety disorder as a hidden psychiatric comorbidity among cancer patients. Palliat Support Care, 2011. 9(1): p. 103-5.

Ando, M., T. Morita, T. Akechi, and Y. Ifuku, A qualitative study of mindfulness-based meditation therapy in Japanese cancer patients. Support Care Cancer, 2011. 19(7): p. 929-33.

Ando, M., T. Morita, K. Hirai, T. Akechi, H. Kira, E. Ogasawara, and K. Jingu, Development of a Japanese Benefit Finding scale (JBFS) for patients with cancer. Am J Hosp Palliat Care, 2011. 28(3): p. 171-5.

Azuma, H., A. Yamada, Y. Shinagawa, Y. Nakano, N. Watanabe, T. Akechi, and T.A. Furukawa, Ictal physiological characteristics of remitters during bilateral electroconvulsive therapy. Psychiatry Res, 2011. 185(3): p. 462-4.

Furukawa, T.A., T. Akechi, S. Shimodera, M. Yamada, K. Miki, N. Watanabe, M. Inagaki, and N. Yonemoto, Strategic use of new generation antidepressants for depression: SUN(^_^)D study protocol. Trials, 2011. 12: p. 116.

Furukawa, T.A., T. Akechi, S. Wagenpfeil, and S. Leucht, Relative indices of treatment effect may be constant across different definitions of response in schizophrenia trials. Schizophr Res, 2011. 126(1-3): p. 212-9.

Furukawa, T.A., H. Azuma, H. Takeuchi, T. Kitamura, and K. Takahashi, 10-year course of social adjustment in major depression. International Journal of Social Psychiatry, 2011. 57(5): p. 501-508.

Hashimoto, N., S. Nakaaki, I.M. Omori, J. Fujioi, Y. Noguchi, Y. Murata, J. Sato, H. Tatsumi, K. Torii, M. Mimura, and T.A. Furukawa, Distinct neuropsychological profiles of three major symptom dimensions in obsessive-compulsive disorder Psychiatry Research, 2011. 187: p. 166-173.

Katsuki, F., H. Takeuchi, M. Konishi, M. Sasaki, Y. Murase, A. Naito, H. Toyoda, M. Suzuki, N. Shiraishi, Y. Kubota, Y. Yoshimatsu, and T.A. Furukawa, Pre-post changes in psychosocial functioning among relatives of patients with depressive disorders after Brief Multifamily Psychoeducation: A pilot study. BMC Psychiatry, 2011. 11: p. 56.

Kinoshita, Y., S. Shimodera, A. Nishida, K. Kinoshita, N. Watanabe, N. Oshima, T. Akechi, T. Sasaki, S. Inoue, T.A. Furukawa, and Y. Okazaki, Psychotic-like experiences are associated with violent behavior in adolescents. Schizophr Res, 2011. 126(1-3): p. 245-51.

Kobayakawa, M., M. Inagaki, M. Fujimori, K. Hamazaki, T. Hamazaki, T. Akechi, S. Tsugane, Y. Nishiwaki, K. Goto, K. Hashimoto, S. Yamawaki, and Y. Uchitomi, Serum brain-derived neurotrophic factor and antidepressant-naive major depression after lung cancer diagnosis. Jpn J Clin Oncol, 2011. 41(10): p. 1233-7.

Okuyama, T., T. Akechi, H. Yamashita, T. Toyama, T. Nakaguchi, M. Uchida, and T.A. Furukawa, Oncologists' recognition of supportive care needs and symptoms of their patients in a breast cancer outpatient consultation. Jpn J Clin Oncol, 2011. 41(11): p. 1251-8.

Sagawa, R., A. Yoshida, T. Funayama, T. Okuyama, T. Akechi, and T.A. Furukawa, Case of intrathecal baclofen-induced psychotic symptoms. Psychiatry Clin Neurosci, 2011. 65(3): p. 300-1.

Torii, K., S. Nakaaki, K. Banno, Y. Murata, J. Sato, H. Tatsumi, K. Yamanaka, J. Narumoto, M. Mimura, T. Akechi, and T.A. Furukawa, Reliability and validity of the Japanese version of the Agitated Behaviour in Dementia Scale in Alzheimer's disease: three dimensions of agitated behaviour in dementia. Psychogeriatrics, 2011. 11(4): p. 212-20.

Uchida, M., T. Akechi, T. Okuyama, R. Sagawa, T. Nakaguchi, C. Endo, H. Yamashita, T. Toyama, and T.A. Furukawa, Patients' supportive care needs and psychological distress in advanced breast cancer patients in Japan. Jpn J Clin Oncol, 2011. 41(4): p. 530-6.

Watanabe, N., Fluoxetine, trazodone and ritanserin are more effective than placebo when used as add-on therapies for negative symptoms of schizophrenia. Evid Based Ment Health, 2011. 14(1): p. 21.

Watanabe, N., T.A. Furukawa, S. Shimodera, I. Morokuma, F. Katsuki, H. Fujita, M. Sasaki, C. Kawamura, and M.L. Perlis, Brief behavioral therapy for refractory insomnia in residual depression: an assessor-blind, randomized controlled trial. J Clin Psychiatry, 2011. 72(12): p. 1651-1658.

Watanabe, N., I.M. Omori, A. Nakagawa, A. Cipriani, C. Barbui, R. Churchill, and T.A. Furukawa, Mirtazapine versus other antidepressive agents for depression. Cochrane Database Syst Rev, 2011. 12: p. CD006528.

Akazawa, T., T. Akechi, T. Morita, M. Miyashita, K. Sato, S. Tsuneto, Y. Shima, and T.A. Furukawa, Self-perceived burden in terminally ill cancer patients: A categorization of care strategies based on bereaved family members' perspective. Journal of Pain and Symptom Management, 2010. 40: p. 224-234.

Akechi, T., C. Ishiguro, T. Okuyama, C. Endo, R. Sagawa, M. Uchida, and T.A. Furukawa, Delirium training program for nurses. Psychosomatics, 2010. 51(2): p. 106-11.

Akechi, T., H. Okamura, T. Nakano, N. Akizuki, M. Okamura, K. Shimizu, T. Okuyama, T.A. Furukawa, and Y. Uchitomi, Gender differences in factors associated with suicidal ideation in major depression among cancer patients. Psycho-Oncology, 2010. 19: p. 384-389.

Akechi, T., T. Okuyama, C. Endo, R. Sagawa, M. Uchida, T. Nakaguchi, M. Sakamoto, H. Komatsu, R. Ueda, M. Wada, and T.A. Furukawa, Anticipatory nausea among ambulatory cancer patients undergoing chemotherapy: Prevalence, associated factors, and impact on quality of life. Cancer Sci, 2010. 101(12): p. 2596-600.

Azuma, H., U. Ichikawa, R. Katsumata, T. Akechi, and T.A. Furukawa, Paroxysmal nonkinesigenic dyskinesia with depression treated by bilateral electroconvulsive therapy. J Neuropsychiatry Clin Neurosci, 2010. 22(3): p. 352d e6-352 e6.

Azuma, H., A. Yamada, Y. Shinagawa, Y. Nakano, N. Watanabe, T. Akechi, and T.A. Furukawa, Ictal physiological characteristics of remitter during bilateral electroconvulsive therapy. Psychiatry Res, 2010.

Chen, J., T.A. Furukawa, Y. Nakano, T. Ietsugu, S. Ogawa, T. Funayama, N. Watanabe, Y. Noda, and R.M. Rapee, Video feedback with peer ratings in naturalistic anxiety-provoking situations for social anxiety disorder: Preliminary report. J Behav Ther Exp Psychiatry, 2010. 41(1): p. 6-10.

Furukawa, T.A., Assessment of mood: guides for clinicians. J Psychosom Res, 2010. 68(6): p. 581-9.

Furukawa, T.A., N. Watanabe, and I.M. Omori, What (no) differences in response to three classes of psychotropics can teach us about distinctions between GAD and MDD, in Diagnostic Issues in Depression and Generalized Anxiety Disorder: Refining the Research Agenda for DSM-V, D. Goldberg, et al., Editors. 2010, American Psychiatric Association: Arlington, VA. p. 71-104.

Katsumata, R., R. Sagawa, T. Akechi, Y. Shinagawa, S. Nakaaki, A. Inagaki, T. Okuyama, T. Akazawa, and T.A. Furukawa, A case with Hodgkin lymphoma and fronto-temporal lobular degeneration (FTLD)-like dementia facilitated by chemotherapy. Jpn J Clin Oncol, 2010. 40(4): p. 365-8.

Kessler, R.C., J.G. Green, M.J. Gruber, N.A. Sampson, E. Bromet, M. Cuitan, T.A. Furukawa, O. Gureje, H. Hinkov, C.Y. Hu, C. Lara, S. Lee, Z. Mneimneh, L. Myer, M. Oakley-Browne, J. Posada-Villa, R. Sagar, M.C. Viana, and A.M. Zaslavsky, Screening for serious mental illness in the general population with the K6 screening scale: results from the WHO World Mental Health (WMH) survey initiative. Int J Methods Psychiatr Res, 2010. 19 Suppl 1: p. 4-22.

Kinoshita, Y., D. Kingdon, K. Kinoshita, K. Saka, Y. Arisue, D. Dayson, S. Nakaaki, K. Fukuda, K. Yoshida, S. Harris, and T.A. Furukawa, Fear of negative evaluation is associated with delusional ideation in non-clinical population and patients with schizophrenia. Soc Psychiatry Psychiatr Epidemiol, 2010.

Kojima, M., J. Hayano, S. Suzuki, H. Seno, H. Kasuga, H. Takahashi, T. Toriyama, H. Kawahara, and T.A. Furukawa, Depression, Alexithymia and Long-Term Mortality in Chronic Hemodialysis Patients. Psychother Psychosom, 2010. 79(5): p. 303-311.

Kojima, M., T. Kojima, N. Ishiguro, and T.A. Furukawa, Exploring the link between depression and rheumatoid arthritis: prospects for optimal therapeutic success. International Journal of Clinical Rheumatology, 2010. 5(3): p. 273-275.

Ogawa, S., T.A. Furukawa, Y. Nakano, T. Funayama, N. Watanabe, Y. Noguchi, and M. Sasaki, Interoceptive hypersensitivity as prognostic factor among patients with panic disorder who have received cognitive behavioral therapy. J Behav Ther Exp Psychiatry, 2010. 41(3): p. 325-9.

Omori, I.M., N. Watanabe, A. Nakagawa, A. Cipriani, C. Barbui, H. McGuire, R. Churchill, and T.A. Furukawa, Fluvoxamine versus other anti-depressive agents for depression. Cochrane Database Syst Rev, 2010. 3: p. CD006114.

Saito, M., N. Iwata, N. Kawakami, Y. Matsuyama, Y. Ono, Y. Nakane, Y. Nakamura, H. Tachimori, H. Uda, H. Nakane, M. Watanabe, Y. Naganuma, T.A. Furukawa, Y. Hata, M. Kobayashi, Y. Miyake, T. Takeshima, and T. Kikkawa, Evaluation of the DSM-IV and ICD-10 criteria for depressive disorders in a community population in Japan using item response theory. Int J Methods Psychiatr Res, 2010. 19(4): p. 211-22.

Suzuki, Y., T.A. Furukawa, N. Kawakami, I. Horiguchi, K. Ishimaru, and Y. Kim, Predictors for psychological distress after the Niigata-Chuetsu earthquake in Japan using pre-disaster physical health indicators. Journal of Mental Health (Seishin-Hoken-Kenkyu), 2010. 56: p. 89-97.

Watanabe, N., T.A. Furukawa, J. Chen, Y. Kinoshita, Y. Nakano, S. Ogawa, T. Funayama, T. Ietsugu, and Y. Noda, Change in quality of life and their predictors in the long-term follow-up after group cognitive behavioral therapy for social anxiety disorder: a prospective cohort study. BMC Psychiatry, 2010. 10: p. 81.

Watanabe, N., I.M. Omori, A. Nakagawa, A. Cipriani, C. Barbui, H. McGuire, R. Churchill, and T.A. Furukawa, Safety reporting and adverse-event profile of mirtazapine described in randomized controlled trials in comparison with other classes of antidepressants in the acute-phase treatment of adults with depression: systematic review and meta-analysis. CNS Drugs, 2010. 24(1): p. 35-53.

Akechi, T., T. Ietsugu, M. Sukigara, H. Okamura, T. Nakano, N. Akizuki, M. Okamura, K. Shimizu, T. Okuyama, T.A. Furukawa, and Y. Uchitomi, Symptom indicator of severity of depression in cancer patients: a comparison of the DSM-IV criteria with alternative diagnostic criteria. Gen Hosp Psychiatry, 2009. 31(3): p. 225-32.

Akechi, T., H. Okamura, T. Okuyama, T.A. Furukawa, Y. Nishiwaki, and Y. Uchitomi, Psychosocial factors and survival after diagnosis of inoperable non-small cell lung cancer. Psychooncology, 2009. 18(1): p. 23-29.

Azuma, H., K. Segawa, S. Nakaaki, Y. Murata, K. Kawakami, J. Tohyama, T. Iidaka, Y. Shinagawa, Y. Nakano, A. Yamada, N. Watanabe, J. Hongo, T. Akechi, and T.A. Furukawa, Neural correlates of memory in depression measured by brain perfusion SPECT at rest. Psychiatry Clin Neurosci, 2009. 63(5): p. 685-92.

Barbui, C., A. Cipriani, T.A. Furukawa, G. Salanti, J.P. Higgins, R. Churchill, N. Watanabe, A. Nakagawa, I.M. Omori, and J.R. Geddes, Making the best use of available evidence: the case of new generation atidepressants. A response to: Are all antidepressants equal? Evidence-Based Mental Health, 2009. 12(4): p. 101-104.

Chen, J., M. Tsuchiya, N. Kawakami, and T.A. Furukawa, Non-fearful vs fearful panic attacks: A general population study from the National Comorbidity Survey. Journal of Affective Disorders, 2009. 112(1-3): p. 273-278.

Cipriani, A., T.A. Furukawa, G. Salanti, J.R. Geddes, J.P. Higgins, R. Churchill, N. Watanabe, A. Nakagawa, I.M. Omori, H. McGuire, M. Tansella, and C. Barbui, Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet, 2009. 373: p. 746-758.

Cipriani, A., J.R. Geddes, T.A. Furukawa, G. Salanti, and C. Barbui, Ranking antidepressants -- Authors' reply. Lancet, 2009. 373(9677): p. 1761-1762.

Cipriani, A., T. La Ferla, T.A. Furukawa, A. Signoretti, A. Nakagawa, R. Churchill, H. McGuire, and C. Barbui, Sertraline versus other antidepressive agents for depression. Cochrane Database Syst Rev, 2009(2): p. CD006117.

Cipriani, A., C. Santilli, T.A. Furukawa, A. Signoretti, A. Nakagawa, H. McGuire, R. Churchill, and C. Barbui, Escitalopram versus other antidepressive agents for depression. Cochrane Database Syst Rev, 2009(2): p. CD006532.

Elamin, M.B., D.N. Flynn, D. Bassler, M. Briel, P. Alonso-Coello, P.J. Karanicolas, G.H. Guyatt, G. Malaga, T.A. Furukawa, R. Kunz, H. Schunemann, M.H. Murad, C. Barbui, A. Cipriani, and V.M. Montori, Choice of data extraction tools for systematic reviews depends on resources and review complexity. J Clin Epidemiol, 2009. 62(5): p. 506-10.

Faravelli, C., T.A. Furukawa, and E. Truglia, Panic disorder, in Stress-Induced and Fear Circuitry Disorders: Refining the Research Agenda for DSM-V, G. Andrews, et al., Editors. 2009, American Psychiatric Association: Arlington, VA. p. 31-58.

Furukawa, T.A., A stepped-care prevention programme decreased depression and anxiety disorders in elderly patients. Evid Based Med, 2009. 14(5): p. 146.

Furukawa, T.A., J. Chen, N. Watanabe, Y. Nakano, T. Ietsugu, S. Ogawa, T. Funayama, and Y. Noda, Videotaped experiments to drop safety behaviors and self-focused attention for patients with social anxiety disorder: Do they change subjective and objective evaluations of anxiety and performance? Journal of Behavior Therapy and Experimental Psychiatry, 2009. 40(2): p. 202-210.

Furukawa, T.A., M. Katherine Shear, D.H. Barlow, J.M. Gorman, S.W. Woods, R. Money, E. Etschel, R.R. Engel, and S. Leucht, Evidence-based guidelines for interpretation of the Panic Disorder Severity Scale. Depress Anxiety, 2009. 26(10): p. 922-9.

Furukawa, T.A., R. Yoshimura, H. Harai, T. Imaizumi, H. Takeuchi, T. Kitamura, and K. Takahashi, How many well vs. unwell days can you expect over 10 years, once you become depressed? Acta Psychiatr Scand, 2009. 119(4): p. 290-297.

Kinoshita, Y., M. Tsuchiya, N. Kawakami, T.A. Furukawa, and D. Kingdon, Hallucinations in visually impaired individuals : An analysis of the National Comorbidity Survey Replication. Soc Psychiatry Psychiatr Epidemiol, 2009. 44(2): p. 104-8.

Kojima, M., T. Kojima, N. Ishiguro, T. Oguchi, M. Oba, H. Tsuchiya, F. Sugiura, T.A. Furukawa, S. Suzuki, and S. Tokudome, Psychosocial factors, disease status, and quality of life in patients with rheumatoid arthritis. J Psychosom Res, 2009. 67(5): p. 425-31.

Kojima, M., T. Kojima, S. Suzuki, T. Oguchi, M. Oba, H. Tsuchiya, F. Sugiura, Y. Kanayama, T.A. Furukawa, S. Tokudome, and N. Ishiguro, Depression, inflammation, and pain in patients with rheumatoid arthritis. Arthritis Rheum, 2009. 61(8): p. 1018-24.

Martin-Sanchez, E., T.A. Furukawa, J. Taylor, and J.L. Martin, Systematic review and meta-analysis of cannabis treatment for chronic pain. Pain Med, 2009. 10(8): p. 1353-68.

Nakagawa, A., N. Watanabe, I.M. Omori, C. Barbui, A. Cipriani, H. McGuire, R. Churchill, and T.A. Furukawa, Milnacipran versus other antidepressive agents for depression. Cochrane Database Syst Rev, 2009(3): p. CD006529.

Okuyama, T., T. Akechi, H. Yamashita, T. Toyama, C. Endo, R. Sagawa, M. Uchida, and T.A. Furukawa, Reliability and validity of the Japanese version of the Short-form Supportive Care Needs Survey Questionnaire (SCNS-SF34-J). Psychooncology, 2009.

Okuyama, T., C. Endo, T. Seto, M. Kato, N. Seki, T. Akechi, T.A. Furukawa, K. Eguchi, and T. Hosaka, Cancer patients' reluctance to discuss psychological distress with their physicians was not associated with underrecognition of depression by physicians: a preliminary study. Palliat Support Care, 2009. 7(2): p. 229-33.

Omori, I.M., N. Watanabe, A. Nakagawa, T. Akechi, A. Cipriani, C. Barbui, H. McGuire, R. Churchill, and T.A. Furukawa, Efficacy, tolerability and side-effect profile of fluvoxamine for major depression: meta-analysis. J Psychopharmacol, 2009. 23(5): p. 539-50.

Sagawa, R., T. Akechi, T. Okuyama, M. Uchida, and T.A. Furukawa, Etiologies of delirium and their relationship to reversibility and motor subtype in cancer patients. Jpn J Clin Oncol, 2009. 39(3): p. 175-82.

Tatsumi, H., S. Nakaaki, K. Torii, Y. Shinagawa, N. Watanabe, Y. Murata, J. Sato, M. Mimura, and T.A. Furukawa, Neuropsychiatric symptoms predict change in quality of life of Alzheimer disease patients: a two-year follow-up study. Psychiatry Clin Neurosci, 2009. 63(3): p. 374-84.

Tominaga, M., N. Kawakami, Y. Ono, Y. Nakane, Y. Nakamura, H. Tachimori, N. Iwata, H. Uda, H. Nakane, M. Watanabe, Y. Naganuma, T.A. Furukawa, Y. Hata, M. Kobayashi, Y. Miyake, T. Takeshima, and T. Kikkawa, Prevalence and correlates of illicit and non-medical use of psychotropic drugs in Japan : Findings from the World Mental Health Japan Survey 2002-2004. Soc Psychiatry Psychiatr Epidemiol, 2009. 44: p. 777-783.

Tsuchiya, M., N. Kawakami, Y. Ono, Y. Nakane, Y. Nakamura, H. Tachimori, N. Iwata, H. Uda, H. Nakane, M. Watanabe, Y. Naganuma, T.A. Furukawa, Y. Hata, M. Kobayashi, Y. Miyake, T. Takeshima, T. Kikkawa, and R.C. Kessler, Lifetime comorbidities between phobic disorders and major depression in Japan: results from the World Mental Health Japan 2002-2004 Survey. Depress Anxiety, 2009. 26(10): p. 949-55.

Watanabe, N., R. Churchill, and T.A. Furukawa, Combined psychotherapy plus benzodiazepines for panic disorder. Cochrane Database Syst Rev, 2009(1): p. CD005335.

Yamanishi, T., S. Nakaaki, I.M. Omori, N. Hashimoto, Y. Shinagawa, J. Hongo, M. Horikoshi, J. Tohyama, T. Akechi, T. Soma, T. Iidaka, and T.A. Furukawa, Changes after behavior therapy among responsive and nonresponsive patients with obsessive-compulsive disorder. Psychiatry Res, 2009. 172(3): p. 242-50.

Akechi, T., K. Hirai, H. Motooka, M. Shiozaki, J. Chen, K. Momino, T. Okuyama, and T.A. Furukawa, Problem-solving therapy for psychological distress in Japanese cancer patients: preliminary clinical experience from psychiatric consultations. Jpn J Clin Oncol, 2008. 38(12): p. 867-70.

Akechi, T., T. Okuyama, J. Onishi, T. Morita, and T.A. Furukawa, Psychotherapy for depression among incurable cancer patients. Cochrane Database Syst Rev, 2008(1): p. CD005537.

Azuma, H., T. Akechi, and T.A. Furukawa, Absence status associated with focal activity and polydipsia-induced hyponatremia. Neuropsychiatr Dis Treat, 2008. 4(2): p. 495-8.

Barbui, C., T.A. Furukawa, and A. Cipriani, Effectiveness of paroxetine in the acute phase treatment of adults with major depression: a systematic re-examination of published and unpublished randomised data. Canadian Medical Association Journal, 2008. 178(3): p. 296-305.

Barbui, C., T.A. Furukawa, and A. Cipriani, Effectiveness of serotonin reuptake inhibitors. Canadian Medical Association Journal, 2008. 178(9): p. 1185-1186.

Cipriani, A., T.A. Furukawa, J.R. Geddes, L. Malvini, A. Signoretti, H. McGuire, R. Churchill, A. Nakagawa, and C. Barbui, Does randomized evidence support sertraline as first-line antidepressant for adults with acute major depression? A systematic review and meta-analysis. J Clin Psychiatry, 2008. 69(11): p. 1732-42.

Endo, C., T. Akechi, T. Okuyama, T. Seto, M. Kato, N. Seki, K. Eguchi, T. Hosaka, and T.A. Furukawa, Patient-perceived barriers to the psychological care of Japanese patients with lung cancer. Jpn J Clin Oncol, 2008. 38(10): p. 653-60.

Fujita, A., H. Azuma, T. Kitamura, K. Takahasi, T. Akechi, and T.A. Furukawa, Adequacy of continuation and maintenance treatments for major depression in Japan. Journal of Psychopharmacology, 2008. 22(2): p. 153-156.

Furukawa, T.A., A. Fujita, H. Harai, R. Yoshimura, T. Kitamura, and K. Takahashi, Definitions of recovery and outcomes of major depression: results from a 10-year follow-up. Acta Psychiatr Scand, 2008. 117(1): p. 35-40.

Furukawa, T.A., R. Jaeschke, D. Cook, and G. Guyatt, Measurement of patients' experience, in Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice, G. Guyatt, et al., Editors. 2008, The McGraw-Hill Companies, Inc.: New York. p. 249-271.

Furukawa, T.A., N. Kawakami, M. Saitoh, Y. Ono, Y. Nakane, Y. Nakamura, H. Tachimori, N. Iwata, H. Uda, H. Nakane, M. Watanabe, Y. Naganuma, Y. Hata, M. Kobayashi, Y. Miyake, T. Takeshima, and T. Kikkawa, The performance of the Japanese version of the K6 and K10 in the World Mental Health Survey Japan. Int J Methods Psychiatr Res, 2008. 17(3): p. 152-8.

Furukawa, T.A., S. Strauss, H.C. Bucher, and G. Guyatt, Diagnostic tests, in Users' Guides to the Medical Literature: Essentials of Evidence-Based Practice, G. Guyatt, et al., Editors. 2008, The McGraw-Hill Companies, Inc.: New York. p. 195-222.

Guyatt, G. and T.A. Furukawa, An illustration of bias and random error, in Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice, G. Guyatt, et al., Editors. 2008, The McGraw-Hill Companies, Inc.: New York. p. 109-112.

Hongo, J., S. Nakaaki, Y. Shinagawa, Y. Murata, J. Sato, H. Tatsumi, J. Tohyama, T. Soma, T. Iidaka, T. Fukui, M. Mimura, and T.A. Furukawa, SPECT-identified neuroanatomical predictor of the cognitive effects of donepezil treatment in patients with Alzheimer's disease. Dement Geriatr Cogn Disord, 2008. 26(6): p. 556-66.

Kawakami, N., Y. Ono, Y. Nakane, Y. Nakamura, H. Tachimori, N. Iwata, H. Uda, H. Nakane, M. Watanabe, Y. Naganuma, T.A. Furukawa, Y. Hata, M. Kobayashi, Y. Miyake, T. Takeshima, and T. Kikkawa, Twelve-month prevalence, severity, and treatment of common mental disorders in communities in Japan: The World Mental Health Japan 2002-2004 Survey, in World Mental Health Survey: Global Perspectives on the Epidemiology of Mental Disorders, R.C. Kessler and T.B. Ustun, Editors. 2008, Cambridge University Press: New York. p. 474-485.

Kinoshita, Y., J. Chen, R.M. Rapee, S. Bogels, F.R. Schneier, Y. Choy, J.H. Kwon, X. Liu, E. Schramm, D.A. Chavira, Y. Nakano, N. Watanabe, T. Ietzugu, S. Ogawa, P. Emmelkamp, J. Zhang, D. Kingdon, T. Nagata, and T.A. Furukawa, Cross-cultural study of conviction subtype Taijin Kyofu: proposal and reliability of Nagoya-Osaka diagnostic criteria for social anxiety disorder. J Nerv Ment Dis, 2008. 196(4): p. 307-13.

Kojima, M., J. Hayano, H. Fukuta, S. Sakata, S. Mukai, N. Ohte, H. Seno, T. Toriyama, H. Kawahara, T.A. Furukawa, and S. Tokudome, Loss of fractal heart rate dynamics in depressive hemodialysis patients. Psychosom Med, 2008. 70(2): p. 177-85.

Nakaaki, S., Y. Murata, and T.A. Furukawa, Efficacy of olanzapine augmentation of paroxetine therapy in patients with severe body dysmorphic disorder. Psychiatry Clin Neurosci, 2008. 62(3): p. 370.

Nakaaki, S., Y. Murata, J. Sato, Y. Shinagawa, J. Hongo, H. Tatsumi, N. Hirono, M. Mimura, and T.A. Furukawa, Association between apathy/depression and executive function in patients with Alzheimer's disease. Int Psychogeriatr, 2008. 20(5): p. 964-75.

Nakaaki, S., Y. Murata, J. Sato, Y. Shinagawa, J. Hongo, H. Tatsumi, N. Hirono, M. Mimura, and T.A. Furukawa, Impact of depression on insight into memory capacity in patients with Alzheimer disease. Alzheimer Dis Assoc Disord, 2008. 22(4): p. 369-74.

Nakagawa, A., N. Watanabe, I.M. Omori, C. Barbui, A. Cipriani, H. McGuire, R. Churchill, and T.A. Furukawa, Efficacy and tolerability of milnacipran in the treatment of major depression in comparison with other antidepressants : A systematic review and meta-analysis. CNS Drugs, 2008. 22(7): p. 587-602.

Nakano, Y., K. Lee, Y. Noda, S. Ogawa, Y. Kinoshita, T. Funayama, N. Watanabe, J. Chen, Y. Noguchi, and T.A. Furukawa, Cognitive-behavior therapy for Japanese patients with panic disorder: acute phase and one-year follow-up results. Psychiatry Clin Neurosci, 2008. 62(3): p. 313-21.

Okuyama, T., T. Akechi, Y. Shima, Y. Sugahara, H. Okamura, T. Hosaka, T.A. Furukawa, and Y. Uchitomi, Factors correlated with fatigue in terminally ill cancer patients: a longitudinal study. J Pain Symptom Manage, 2008. 35(5): p. 515-23.

Okuyama, T., C. Endo, T. Seto, M. Kato, N. Seki, T. Akechi, T.A. Furukawa, K. Eguchi, and T. Hosaka, Cancer patients' reluctance to disclose their emotional distress to their physicians: a study of Japanese patients with lung cancer. Psychooncology, 2008. 17(5): p. 460-5.

Ono, Y., N. Kawakami, Y. Nakane, Y. Nakamura, H. Tachimori, N. Iwata, H. Uda, H. Nakane, M. Watanabe, Y. Naganuma, T.A. Furukawa, Y. Hata, M. Kobayashi, Y. Miyake, M. Tajima, T. Takeshima, and T. Kikkawa, Prevalence of and risk factors for suicide-related outcomes in the World Health Organization World Mental Health Surveys Japan. Psychiatry Clin Neurosci, 2008. 62(4): p. 442-9.

Takasaki, Y., N. Kawakami, M. Tsuchiya, Y. Ono, Y. Nakane, Y. Nakamura, H. Tachimori, N. Iwata, H. Uda, H. Nakane, M. Watanabe, Y. Naganuma, T. Furukawa, Y. Hata, M. Kobayashi, Y. Miyake, T. Takeshima, and T. Kikkawa, Heart disease, other circulatory diseases, and onset of major depression among community residents in Japan: results of the World Mental Health Survey Japan 2002-2004. Acta Med Okayama, 2008. 62(4): p. 241-9.

Watanabe, N., I.M. Omori, A. Nakagawa, A. Cipriani, C. Barbui, H. McGuire, R. Churchill, and T.A. Furukawa, Mirtazapine versus other antidepressants in the acute-phase treatment of adults with major depression: Systematic review and meta-analysis. Journal of Clinical Psychiatry, 2008. 69: p. 1404-1415.

Watanabe, N., R. Stewart, R. Jenkins, D.K. Bhugra, and T.A. Furukawa, The epidemiology of chronic fatigue, physical illness, and symptoms of common mental disorders: A cross-sectional survey from the second British National Survey of Psychiatric Morbidity. J Psychosom Res, 2008. 64(4): p. 357-62.

Akechi, T., T. Okuyama, N. Akizuki, K. Shimizu, M. Inagaki, M. Fujimori, Y. Shima, T.A. Furukawa, and Y. Uchitomi, Associated and predictive factors of sleep disturbance in advanced cancer patients. Psychooncology, 2007. 16: p. 888-894.

Akechi, T., K. Taniguchi, S. Suzuki, M. Okamura, H. Minami, T. Okuyama, T.A. Furukawa, and Y. Uchitomi, Multifaceted psychosocial intervention program for breast cancer patients after first recurrence: feasibility study. Psychooncology, 2007. 16(6): p. 517-24.

Azuma, H., A. Fujita, K. Otsuki, Y. Nakano, T. Kamao, C. Nakamura, J. Fujioi, H. Otake, M. Nishigaki, M. Suzuki, M. Kataoka, T. Matsuzawa, M. Sonoda, S. Nakaaki, Y. Murata, T. Akechi, and T.A. Furukawa, Ictal electroencephalographic correlates of posttreatment neuropsychological changes in electroconvulsive therapy: a hypothesis-generation study. J ECT, 2007. 23(3): p. 163-8.

Azuma, H., A. Fujita, K. Sato, K. Arahata, K. Otsuki, M. Hori, Y. Mochida, M. Uchida, T. Yamada, T. Akechi, and T.A. Furukawa, Postictal suppression correlates with therapeutic efficacy for depression in bilateral sine and pulse wave electroconvulsive therapy. Psychiatry Clin Neurosci, 2007. 61(2): p. 168-73.

Azuma, H., A. Fujita, K. Sato, K. Arahata, K. Otsuki, M. Hori, Y. Mochida, M. Uchida, T. Yamada, T. Akechi, and T.A. Furukawa, Postictal cardiovascular response predicts therapeutic efficacy of electroconvulsive therapy for depression. Psychiatry Clin Neurosci, 2007. 61(3): p. 290-4.

Azuma, H., A. Negi, M. Hattori, T. Masayasu, T. Akechi, and T.A. Furukawa, Neuroleptic malignant syndrome-like state in an epileptic patient with organic brain comorbidity treated with zonisamide and carbamazepine. Epilepsia, 2007. 48(10): p. 1999-2001.

Chen, J., Y. Nakano, T. Ietzugu, S. Ogawa, T. Funayama, N. Watanabe, Y. Noda, and T.A. Furukawa, Group cognitive behavior therapy for Japanese patients with social anxiety disorder: preliminary outcomes and their predictors. BMC Psychiatry, 2007. 7(1): p. 69.

Cipriani, A., T.A. Furukawa, R. Churchill, and C. Barbui, Validity of indirect comparisons in meta-analysis. Lancet, 2007. 369(9558): p. 270-1; author reply 271.

Cipriani, A., J.R. Geddes, T.A. Furukawa, and C. Barbui, Metareview on short-term effectiveness and safety of antidepressants for depression: an evidence-based approach to inform clinical practice. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie, 2007. 52(9): p. 553-562.

Cipriani, A., L. Malvini, T.A. Furukawa, and C. Barbui, Relationship between quality of reports of antidepressant randomized controlled trials and treatment estimates: Systematic review, meta-analysis, and meta-regression analysis. J Clin Psychopharmacol, 2007. 27(4): p. 352-356.

Furukawa, T., N. Watanabe, and R. Churchill, Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobia. Cochrane Database Syst Rev, 2007(1): p. CD004364.

Furukawa, T.A., T. Akechi, H. Azuma, T. Okuyama, and T. Higuchi, Evidence-based guidelines for interpretation of the Hamilton Rating Scale for Depression. J Clin Psychopharmacol, 2007. 27(5): p. 531-534.

Furukawa, T.A., A. Cipriani, C. Barbui, and J.R. Geddes, Long-term treatment of depression with antidepressants: A systematic narrative review. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie, 2007. 52(9): p. 545-552.

Furukawa, T.A., N. Watanabe, I.M. Omori, and R. Churchill, Can pill placebo augment cognitive-behavior therapy for panic disorder? BMC Psychiatry, 2007. 7(1): p. 73.

Furukawa, T.A., N. Watanabe, I.M. Omori, V.M. Montori, and G.H. Guyatt, Association between unreported outcomes and effect size estimates in Cochrane meta-analyses. JAMA, 2007. 297(5): p. 468-70.

Geddes, J.R., T.A. Furukawa, A. Cipriani, and C. Barbui, Depressive disorder needs an evidence base commensurate with its public health importance. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie, 2007. 52(9): p. 543-544.

Ietsugu, T., M. Sukigara, and T.A. Furukawa, Evaluation of diagnostic criteria for panic attack using item response theory: Findings from the National Comorbidity Survey in USA. Journal of Affective Disorders, 2007. 104: p. 197-201.

Kojima, M., J. Hayano, S. Tokudome, S. Suzuki, K. Ibuki, H. Tomizawa, A. Nakata, H. Seno, T. Toriyama, H. Kawahara, and T.A. Furukawa, Independent associations of alexithymia and social support with depression in hemodialysis patients. J Psychosom Res, 2007. 63(4): p. 349-56.

Martin, J.L., M. Sainz-Pardo, T.A. Furukawa, E. Martin-Sanchez, T. Seoane, and C. Galan, Review: Benzodiazepines in generalized anxiety disorder: heterogeneity of outcomes based on a systematic review and meta-analysis of clinical trials. J Psychopharmacol, 2007. 21(7): p. 774-82.

Nakaaki, S., Y. Murata, J. Sato, Y. Shinagawa, J. Hongo, H. Tatsumi, M. Mimura, and T.A. Furukawa, Impairment of decision-making cognition in a case of frontotemporal lobar degeneration (FTLD) presenting with pathologic gambling and hoarding as the initial symptoms. Cogn Behav Neurol, 2007. 20(2): p. 121-5.

Nakaaki, S., Y. Murata, J. Sato, Y. Shinagawa, T. Matsui, H. Tatsumi, and T.A. Furukawa, Reliability and validity of the Japanese version of the Frontal Assessment Battery in patients with the frontal variant of frontotemporal dementia. Psychiatry Clin Neurosci, 2007. 61(1): p. 78-83.

Nakaaki, S., Y. Murata, J. Sato, Y. Shinagawa, H. Tatsumi, N. Hirono, and T.A. Furukawa, Greater impairment of ability in the divided attention task is seen in Alzheimer's Disease patients with deepression than in those without Depression. Dement Geriatr Cogn Disord, 2007. 23(4): p. 231-240.

Nakaaki, S., Y. Murata, Y. Shinagawa, J. Hongo, T.A. Furukawa, J. Sato, and H. Tatsumi, A case of late-onset obsessive compulsive disorder developing frontotemporal lobar degeneration. J Neuropsychiatry Clin Neurosci, 2007. 19(4): p. 487-8.

Nakaaki, S., Y. Murata, Y. Shinagawa, J. Hongo, T.A. Furukawa, J. Sato, and H. Tatsumi, A case of frontotemporal lobar degeneration (FTLD) with panic attack as the first symptom. J Neuropsychiatry Clin Neurosci, 2007. 19(4): p. 485-7.

Noda, Y., Y. Nakano, K. Lee, S. Ogawa, Y. Kinoshita, T. Funayama, N. Watanabe, J. Chen, Y. Noguchi, M. Kataoka, M. Suzuki, and T.A. Furukawa, Sensitization of catastrophic cognition in cognitive-behavioral therapy for panic disorder. BMC Psychiatry, 2007. 7(1): p. 70.

Okuyama, T., Y. Nakane, C. Endo, T. Seto, M. Kato, N. Seki, T. Akechi, T.A. Furukawa, K. Eguchi, and T. Hosaka, Mental health literacy in Japanese cancer patients: ability to recognize depression and preferences of treatments-comparison with Japanese lay public. Psychooncology, 2007. 16(9): p. 834-42.

Omori, I.M., Y. Murata, T. Yamanishi, S. Nakaaki, T. Akechi, M. Mikuni, and T.A. Furukawa, The differential impact of executive attention dysfunction on episodic memory in obsessive-compulsive disorder patients with checking symptoms vs. those with washing symptoms. J Psychiatr Res, 2007. 41(9): p. 776-84.

Sartorius, N., T.C. Baghai, D.S. Baldwin, B. Barrett, U. Brand, W. Fleischhacker, G. Goodwin, H. Grunze, M. Knapp, B.E. Leonard, J. Lieberman, Y. Nakane, R.M. Pinder, A.F. Schatzberg, J. Svestka, P. Baumann, K. Ghalib, J.C. Markowitz, F. Padberg, M. Fink, T. Furukawa, K.N. Fountoulakis, P. Jensen, S. Kanba, and A. Riecher-Rossler, Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence. Int J Neuropsychopharmacol, 2007. 10 Suppl 1: p. S1-207.

Sato, J., S. Nakaaki, Y. Murata, Y. Shinagawa, T. Matsui, J. Hongo, H. Tatsumi, T. Akechi, and T.A. Furukawa, Two dimensions of anosognosia in patients with Alzheimer's disease: reliability and validity of the Japanese version of the Anosognosia Questionnaire for Dementia (AQ-D). Psychiatry Clin Neurosci, 2007. 61(6): p. 672-7.

Shinagawa, Y., S. Nakaaki, J. Hongo, Y. Murata, J. Sato, T. Matsui, H. Tatsumi, T. Akechi, and T.A. Furukawa, Reliability and validity of the Japanese version of the Dysexecutive Questionnaire (DEX) in Alzheimer's disease: validation of a behavioral rating scale to assess dysexecutive symptoms in Japanese patients with Alzheimer's disease. Int J Geriatr Psychiatry, 2007. 22(10): p. 951-956.

Tabuse, H., A. Kalali, H. Azuma, N. Ozaki, N. Iwata, H. Naitoh, T. Higuchi, S. Kanba, K. Shioe, T. Akechi, and T.A. Furukawa, The new GRID Hamilton Rating Scale for Depression demonstrates excellent inter-rater reliability for inexperienced and experienced raters before and after training. Psychiatry Res, 2007. 153(1): p. 61-7.

Watanabe, N., R. Churchill, and T.A. Furukawa, Combination of psychotherapy and benzodiazepines versus either therapy alone for panic disorder: a systematic review. BMC Psychiatry, 2007. 7(1): p. 18.

Watanabe, N., V. Hunot, I.M. Omori, R. Churchill, and T.A. Furukawa, Psychotherapy for depression among children and adolescents: a systematic review. Acta Psychiatr Scand, 2007. 116(2): p. 84-95.

Yamada, A., M. Suzuki, M. Kato, S. Tanaka, T. Shindo, K. Taketani, T. Akechi, and T.A. Furukawa, Emotional distress and its correlates among parents of children with pervasive developmental disorders. Psychiatry Clin Neurosci, 2007. 61(6): p. 651-7.

Akechi, T., T. Okuyama, N. Akizuki, H. Azuma, R. Sagawa, T.A. Furukawa, and Y. Uchitomi, Course of psychological distress and its predictors in advanced non-small cell lung cancer patients. Psycho-Oncology, 2006. 15(6): p. 463-73.

Akechi, T., T. Okuyama, Y. Sugawara, Y. Shima, T.A. Furukawa, and Y. Uchitomi, Screening for depression in terminally ill cancer patients in Japan. J Pain Symptom Manage, 2006. 31(1): p. 5-12.

Cipriani, A., C. Barbui, P. Brambilla, T. Furukawa, M. Hotopf, and J. Geddes, Are all antidepressants really the same? The case of fluoxetine: a systematic review. Journal of Clinical Psychiatry, 2006. 67: p. 850-864.

Fujita, A., S. Nakaaki, K. Segawa, H. Azuma, K. Sato, K. Arahata, K. Otsuki, M. Hori, Y. Mochida, M. Uchida, T. Yamada, C. Nakamura, T. Akechi, and T.A. Furukawa, Memory, attention, and executive functions before and after sine and pulse wave electroconvulsive therapies for treatment-resistant major depression. J ECT, 2006. 22(2): p. 107-12.

Furukawa, T.A., C. Barbui, A. Cipriani, P. Brambilla, and N. Watanabe, Imputing missing standard deviations in meta-analyses can provide accurate results. J Clin Epidemiol, 2006. 59(1): p. 7-10.

Furukawa, T.A. and G.H. Guyatt, Sources of bias in studies of diagnostic tests and the diagnostic process. Canadian Medical Association Journal, 2006. 174(4): p. 481-2.

Furukawa, T.A., N. Watanabe, and R. Churchill, Psychotherapy plus antidepressant for panic disorder with or without agoraphobia: systematic review. British Journal of Psychiatry, 2006. 188: p. 305-312.

Honjo, K., N. Kawakami, T. Takeshima, H. Tachimori, Y. Ono, H. Uda, Y. Hata, Y. Nakane, H. Nakane, N. Iwata, T.A. Furukawa, M. Watanabe, Y. Nakamura, and T. Kikkawa, Social class inequalities in self-rated health and their gender and age group differences in Japan. J Epidemiol, 2006. 16(6): p. 223-32.

Kitamura, T., K. Yoshida, T. Okano, K. Kinoshita, M. Hayashi, N. Toyoda, M. Ito, N. Kudo, K. Tada, K. Kanazawa, K. Sakumoto, S. Satoh, T. Furukawa, and H. Nakano, Multicentre prospective study of perinatal depression in Japan: incidence and correlates of antenatal and postnatal depression. Archives of Women's Mental Health, 2006. 9: p. 121-130.

Lee, K., Y. Noda, Y. Nakano, S. Ogawa, Y. Kinoshita, T. Funayama, and T.A. Furukawa, Interoceptive hypersensitivity and interoceptive exposure in patients with panic disorder: specificity and effectiveness. BMC Psychiatry, 2006. 6: p. 32.

Matsui, T., S. Nakaaki, Y. Murata, J. Sato, Y. Shinagawa, H. Tatsumi, and T.A. Furukawa, Determinants of the quality of life in Alzheimer's disease patients as assessed by the Japanese version of the quality of life - Alzheimer's disease scale. Dement Geriatr Cogn Disord, 2006. 21(3): p. 182-91.

Naganuma, Y., H. Tachimori, N. Kawakami, T. Takeshima, Y. Ono, H. Uda, Y. Hata, Y. Nakane, H. Nakane, N. Iwata, T.A. Furukawa, and T. Kikkawa, Twelve-month use of mental health services in four areas in Japan: a preliminary finding from the World Mental Health Japan 2002-2003. Psychiatry and Clinical Neurosciences, 2006. 60(2): p. 240-248.

Okumura, K. and T.A. Furukawa, Remission rates of milnacipran 100 mg/day and 150 mg/day in the long-term treatment of major depression. Clinical Drug Investigation, 2006. 26(3): p. 135-142.

Segawa, K., H. Azuma, K. Sato, T. Yasuda, K. Arahata, K. Otsuki, J. Tohyama, T. Soma, T. Iidaka, S. Nakaaki, and T.A. Furukawa, Regional cerebral blood flow changes in depression after electroconvulsive therapy. Psychiatry Res, 2006. 147(2-3): p. 135-43.

Cipriani, A., P. Brambilla, T. Furukawa, J. Geddes, M. Gregis, M. Hotopf, L. Malvini, and C. Barbui, Fluoxetine versus other types of pharmacotherapy for depression. Cochrane Database Syst Rev, 2005. 4: p. CD004185.

Eguchi, M., Y. Noda, Y. Nakano, T. Kanai, I. Yamamoto, N. Watanabe, K. Lee, S. Ogawa, T. Ietsugu, M. Sasaki, J. Chen, and T.A. Furukawa, Quality of life and social role functioning in Japanese patients with panic disorder. J Nerv Ment Dis, 2005. 193(10): p. 686-9.

Furukawa, T.A., A. Cipriani, C. Barbui, P. Brambilla, and N. Watanabe, Imputing response rates from means and standard deviations in meta-analyses. Int Clin Psychopharmacol, 2005. 20(1): p. 49-52.

Furukawa, T.A., D.L. Streiner, H. Azuma, T. Higuchi, K. Kamijima, S. Kanba, N. Ozaki, A. Aoba, M. Murasaki, and S. Miura, Cross-cultural equivalence in depression assessment: Japan-Europe-North American study. Acta Psychiatr Scand, 2005. 112(4): p. 279-85.

Hiroe, T., M. Kojima, I. Yamamoto, S. Nojima, Y. Kinoshita, N. Hashimoto, N. Watanabe, T. Maeda, and T.A. Furukawa, Gradations of clinical severity and sensitivity to change assessed with the Beck Depression Inventory-II in Japanese patients with depression. Psychiatry Res, 2005. 135(3): p. 229-35.

Kawakami, N., T. Takeshima, Y. Ono, H. Uda, Y. Hata, Y. Nakane, H. Nakane, N. Iwata, T.A. Furukawa, and T. Kikkawa, Twelve-month prevalence, severity, and treatment of common mental disorders in communities in Japan: preliminary finding from the World Mental Health Japan Survey 2002-2003. Psychiatry Clin Neurosci, 2005. 59(4): p. 441-52.

Nishiyama, T., M. Ikeda, N. Iwata, T. Suzuki, T. Kitajima, Y. Yamanouchi, Y. Sekine, M. Iyo, M. Harano, T. Komiyama, M. Yamada, I. Sora, H. Ujike, T. Inada, T. Furukawa, and N. Ozaki, Haplotype association between GABA(A) receptor gamma2 subunit gene (GABRG2) and methamphetamine use disorder. Pharmacogenomics J, 2005. 5(2): p. 89-95.

Sakurai, A., T. Nagata, H. Harai, H. Yamada, I. Mohri, Y. Nakano, Y. Noda, S. Ogawa, K. Lee, and T.A. Furukawa, Is "relationship fear" unique to Japan? Symptom factors and patient clusters of social anxiety disorder among the Japanese clinical population. Journal of Affective Disorders, 2005. 87(1): p. 131-7.

Furukawa, T., Meta-analyses and megatrials: neither is the infallible, universal standard. Evid Based Ment Health, 2004. 7(2): p. 34-5.

Furukawa, T.A., Withdrawal of benzodiazepines in elderly long term users does not produce significant adverse effects in the short term. Evid Based Ment Health, 2004. 7(2): p. 46.

Furukawa, T.A., All clinical trials must be reported in detail and made publicly available. BMJ, 2004. 329(7466): p. 626.

Nakano, Y., M. Oshima, M. Sugiura-Ogasawara, K. Aoki, T. Kitamura, and T.A. Furukawa, Psychosocial predictors of successful delivery after unexplained recurrent spontaneous abortions: a cohort study. Acta Psychiatr Scand, 2004. 109(6): p. 440-6.

Segawa, K., T. Kanai, H. Takeuchi, K. Sato, H. Azuma, T. Matsui, S. Nakaaki, and T. Furukawa, Regional cerebral blood flow before and after ECT: comparison between responders and non-responders. Journal of Affective Disorders, 2004. 78(Supplement 1): p. S110.

Yamamoto, I., Y. Nakano, N. Watanabe, Y. Noda, T.A. Furukawa, T. Kanai, O. Takashio, R. Koda, T. Otsubo, and K. Kamijima, Cross-cultural evaluation of the Panic Disorder Severity Scale in Japan. Depress Anxiety, 2004. 20(1): p. 17-22.

Azuma, H., S. Hori, M. Nakanishi, S. Fujimoto, N. Ichikawa, and T.A. Furukawa, An intervention to improve the interrater reliability of clinical EEG interpretations. Psychiatry Clin Neurosci, 2003. 57(5): p. 485-9.

Furukawa, T., [Critical appraisal of evidence on diagnostic tests]. Rinsho Byori, 2003. 51(1): p. 19-23.

Furukawa, T., H. McGuire, and C. Barbui, Low dosage tricyclic antidepressants for depression. Cochrane Database Syst Rev, 2003(3): p. CD003197.

Furukawa, T.A., Effectiveness: the treatment of panic disorder in the real world. Current Opinion in Psychiatry, 2003. 16: p. 45-48.

Furukawa, T.A., R.C. Kessler, T. Slade, and G. Andrews, The performance of the K6 and K10 screening scales for psychological distress in the Australian National Survey of Mental Health and Well-Being. Psychol Med, 2003. 33(2): p. 357-62.

Geddes, J.R., S.M. Carney, C. Davies, T.A. Furukawa, D.J. Kupfer, E. Frank, and G.M. Goodwin, Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet, 2003. 361(9358): p. 653-61.

Inada, T., S. Nozaki, A. Inagaki, and T.A. Furukawa, Efficacy of diazepam as an anti-anxiety agent: meta-analysis of double-blind, randomized controlled trials carried out in Japan. Hum Psychopharmacol, 2003. 18(6): p. 483-7.

Kanai, T., H. Takeuchi, T.A. Furukawa, R. Yoshimura, T. Imaizumi, T. Kitamura, and K. Takahashi, Time to recurrence after recovery from major depressive episodes and its predictors. Psychol Med, 2003. 33(5): p. 839-45.

Kojima, M., Y. Senda, T. Nagaya, S. Tokudome, and T.A. Furukawa, Alexithymia, depression and social support among Japanese workers. Psychother Psychosom, 2003. 72(6): p. 307-14.

Suzuki, Y., A. Sakurai, T. Yasuda, H. Harai, T. Kitamura, K. Takahashi, and T.A. Furukawa, Reliability, validity and standardization of the Japanese version of the Social Adjustment Scale-Self Report. Psychiatry Clin Neurosci, 2003. 57(4): p. 441-6.

Takeuchi, H., T. Hiroe, T. Kanai, S. Morinobu, T. Kitamura, K. Takahashi, and T.A. Furukawa, Childhood parental separation experiences and depressive symptomatology in acute major depression. Psychiatry Clin Neurosci, 2003. 57(2): p. 215-9.

Yamada, K., H. Nagayama, K. Tsutiyama, T. Kitamura, and T. Furukawa, Coping behavior in depressed patients: a longitudinal study. Psychiatry Res, 2003. 121(2): p. 169-77.

Furukawa, T.A., Review: placebo is better than no treatment for subjective continuous outcomes and for treatment of pain. Evid Based Ment Health, 2002. 5(1): p. 15.

Furukawa, T.A., Overview of recent research on premorbid personality of mood disorders in Japan, in Recent Advances in the Research of Affective Disorders in Japan, T. Okuma, S. Kanba, and Y. Inoue, Editors. 2002, Elsevier: Tokyo. p. 23-35.

Furukawa, T.A., G. Andrews, and D.P. Goldberg, Stratum-specific likelihood ratios of the general health questionnaire in the community: help-seeking and physical co-morbidity affect the test characteristics. Psychol Med, 2002. 32(4): p. 743-8.

Furukawa, T.A., G.H. Guyatt, and L.E. Griffith, Can we individualize the 'number needed to treat'? An empirical study of summary effect measures in meta-analyses. Int J Epidemiol, 2002. 31(1): p. 72-6.

Furukawa, T.A., S. Hori, H. Azuma, Y. Nakano, M. Oshima, T. Kitamura, M. Ogasawara Sugiura, and K. Aoki, Parents, personality or partner? Correlates of marital relationships. Soc Psychiatry Psychiatr Epidemiol, 2002. 37(4): p. 164-8.

Furukawa, T.A., T. Inada, C.E. Adams, H. McGuire, A. Inagaki, and S. Nozaki, Are the Cochrane group registers comprehensive? A case study of Japanese psychiatry trials. BMC Med Res Methodol, 2002. 2(1): p. 6.

Furukawa, T.A., H. McGuire, and C. Barbui, Meta-analysis of effects and side effects of low dosage tricyclic antidepressants in depression: systematic review. BMJ, 2002. 325(7371): p. 991-995.

Hori, S., Y. Nakano, A. Yamada, H. Azuma, Y. Noda, M. Sugiura, K. Aoki, T. Kitamura, and T.A. Furukawa, Personality, social support, coping and emotional distress after repeated spontaneous abortions. J Psychosom Obstet Gynaecol, 2002. 23(2): p. 133-40.

Kojima, M., T.A. Furukawa, H. Takahashi, M. Kawai, T. Nagaya, and S. Tokudome, Cross-cultural validation of the Beck Depression Inventory-II in Japan. Psychiatry Res, 2002. 110(3): p. 291-9.

Nakaaki, S., M. Nakanishi, N. Fujiwara, H. Hamajima, H. Nakamura, S. Yoshida, J. Sato, H. Tatsumi, K. Furuhashi, T. Furukawa, L.T. Connor, K.C. Lindfield, and M.L. Albert, Cognitive patterns of good and poor namers in old age. Psychogeriatrics, 2002. 2: p. 35-39.

Nakaaki, S., J. Sato, H. Nakamura, S. Yoshida, K. Furuhashi, T. Furukawa, and I. Takabayashi, Exploring the role of the right temporal lobe in person-specific knowledge: a case study of semantic dementia associated with right temporal atrophy. Psychogeriatrics, 2002. 2: p. 54-61.

Nakaaki, S., H. Watanabe, H. Nakamura, S. Yoshida, T. Matsui, Y. Kinoshita, and T. Furukawa, The influence of the Stroop interference effect on an event-based prospective memory task in Alzheimer's disease patients. Psychogeriatrics, 2002. 2: p. 120-126.

Nakano, Y., M. Sugiura, K. Aoki, S. Hori, M. Oshima, T. Kitamura, and T.A. Furukawa, Japanese version of the Quality of Relationship Inventory: its reliability and validity among women with recurrent spontaneous abortion. Psychiatry Clin Neurosci, 2002. 56(5): p. 527-32.

Sugiura-Ogasawara, M., T.A. Furukawa, Y. Nakano, S. Hori, K. Aoki, and T. Kitamura, Depression as a potential causal factor in subsequent miscarriage in recurrent spontaneous aborters. Hum Reprod, 2002. 17(10): p. 2580-4.

Ueno, S., J. Ito, Y. Nagayasu, T. Furukawa, and S. Yokoyama, An acidic fibroblast growth factor-like factor secreted into the brain cell culture medium upregulates apoE synthesis, HDL secretion and cholesterol metabolism in rat astrocytes. Biochim Biophys Acta, 2002. 1589(3): p. 261-72.

Furukawa, T.A., Psychosocial treatment for schizophrenia. Am J Psychiatry, 2001. 158(12): p. 2092-3.

Furukawa, T.A., Prognosis of depression and generalised anxiety in primary care. Br J Psychiatry, 2001. 179: p. 177-8.

Furukawa, T.A., D.P. Goldberg, S. Rabe-Hesketh, and T.B. Ustun, Stratum-specific likelihood ratios of two versions of the general health questionnaire. Psychol Med, 2001. 31(3): p. 519-29.

Furukawa, T.A., D.L. Streiner, and L.T. Young, Is antidepressant-benzodiazepine combination therapy clinically more useful? A meta-analytic study. J Affect Disord, 2001. 65(2): p. 173-7.

Furukawa, T.A., D.L. Streiner, L.T. Young, and Y. Kinoshita, Antidepressants plus benzodiazepine for major depression. Cochrane Database Syst Rev, 2001: p. Art. No.: CD001026. DOI: 10.1002/14651858.CD001026.

Furukawa, T.A., H. Takeuchi, T. Hiroe, H. Mashiko, K. Kamei, T. Kitamura, and K. Takahashi, Symptomatic recovery and social functioning in major depression. Acta Psychiatr Scand, 2001. 103(4): p. 257-61.

Ito, S., H. Takeuchi, and T.A. Furukawa, Cognitive therapy and social functioning in chronic depression. Br J Psychiatry, 2001. 178: p. 477-8.

Furukawa, T., D.L. Streiner, and L.T. Young, Antidepressant plus benzodiazepine for major depression. Cochrane Database Syst Rev, 2000(4): p. CD001026.

Furukawa, T.A., T. Kitamura, and K. Takahashi, Time to recovery of an inception cohort with hitherto untreated unipolar major depressive episodes. Br J Psychiatry, 2000. 177: p. 331-5.

Furukawa, T.A., T. Kitamura, and K. Takahashi, Treatment received by depressed patients in Japan and its determinants: naturalistic observation from a multi-center collaborative follow-up study. J Affect Disord, 2000. 60(3): p. 173-9.

Furukawa, T.A., W. Konno, S. Morinobu, H. Harai, T. Kitamura, and K. Takahashi, Course and outcome of depressive episodes: comparison between bipolar, unipolar and subthreshold depression. Psychiatry Res, 2000. 96(3): p. 211-20.

Furukawa, T.A., D.L. Streiner, and S. Hori, Discrepancies among megatrials. J Clin Epidemiol, 2000. 53(12): p. 1193-9.

Hori, S., Y. Nakano, T.A. Furukawa, M. Ogasawara, K. Katano, K. Aoki, and T. Kitamura, Psychosocial factors regulating natural-killer cell activity in recurrent spontaneous abortions. Am J Reprod Immunol, 2000. 44(5): p. 299-302.

Ikawa, M., M. Nakanishi, T. Furukawa, S. Nakaaki, S. Hori, and S. Yoshida, Relationship between EEG dimensional complexity and neuropsychological findings in Alzheimer's disease. Psychiatry and Clinical Neurosciences, 2000. 54: p. 537-541.

Nakamura, H., M. Nakanishi, T.A. Furukawa, T. Hamanaka, and S. Tokudome, Validity of brief intelligence tests for patients with Alzheimer's disease. Psychiatry Clin Neurosci, 2000. 54(4): p. 435-9.

Furukawa, T., Toolbox for evidence-based psychiatry: Cochrane Library, Evidence-Based Mental Health, AHCPR Clinical Practice Guideline, Psychopharmacology Algorithm, APA Practice Guideline. International Clinical Psychopharmacology, 1999. 14: p. 43-44.

Furukawa, T. and D.P. Goldberg, Cultural invariance of likelihood ratios for the General Health Questionnaire. Lancet, 1999. 353(9152): p. 561-2.

Furukawa, T., T. Yokouchi, T. Hirai, T. Kitamura, and K. Takahashi, Parental loss in childhood and social support in adulthood among psychiatric patients. Group for Longitudinal Affective Disorders Study (GLADS). J Psychiatr Res, 1999. 33(2): p. 165-9.

Furukawa, T.A., From effect size into number needed to treat. Lancet, 1999. 353(9165): p. 1680.

Furukawa, T.A., K. Anraku, T. Hiroe, K. Takahashi, R. Yoshimura, T. Hirai, T. Kitamura, and K. Takahashi, A polydiagnostic study of depressive disorders according to DSM-IV and 23 classical diagnostic systems. Psychiatry Clin Neurosci, 1999. 53(3): p. 387-96.

Furukawa, T.A., H. Harai, T. Hirai, T. Kitamura, and K. Takahashi, Social Support Questionnaire among psychiatric patients with various diagnoses and normal controls. Soc Psychiatry Psychiatr Epidemiol, 1999. 34(4): p. 216-22.

Furukawa, T.A., A. Ogura, T. Hirai, S. Fujihara, T. Kitamura, and K. Takahashi, Early parental separation experiences among patients with bipolar disorder and major depression: a case-control study. J Affect Disord, 1999. 52(1-3): p. 85-91.

Hirai, T., T. Furukawa, T. Kitamura, and K. Takahashi, [Mode of onset and two years outcome of a broad spectrum of affective disorders]. Seishin Shinkeigaku Zasshi, 1999. 101(6): p. 495-508.

Aoki, K., T. Furukawa, M. Ogasawara, S. Hori, and T. Kitamura, Psychosocial factors in recurrent miscarriages. Acta Obstet Gynecol Scand, 1998. 77(5): p. 572-3.

Furukawa, T., H. Harai, T. Hirai, S. Fujihara, T. Kitamura, and K. Takahashi, Childhood parental loss and alcohol dependence among Japanese men: a case-control study. Group for Longitudinal Affective Disorders Study (GLADS). Acta Psychiatr Scand, 1998. 97(6): p. 403-7.

Furukawa, T., S. Hori, S. Yoshida, M. Tsuji, M. Nakanishi, and T. Hamanaka, Premorbid personality traits of patients with organic (ICD-10 F0), schizophrenic (F2), mood (F3), and neurotic (F4) disorders according to the five-factor model of personality. Psychiatry Res, 1998. 78(3): p. 179-87.

Furukawa, T., R. Mizukawa, T. Hirai, S. Fujihara, T. Kitamura, and K. Takahashi, Childhood parental loss and schizophrenia: evidence against pathogenic but for some pathoplastic effects. Psychiatry Res, 1998. 81(3): p. 353-62.

Furukawa, T., I.G. Sarason, and B.R. Sarason, Social support and adjustment to a novel social environment. Int J Soc Psychiatry, 1998. 44(1): p. 56-70.

Furukawa, T., H. Takeuchi, T. Hirai, T. Furukawa, H. Takeuchi, T. Hirai, S. Fujihara, T. Kitamura, and K. Takahashi, A possible association between paternal longevity and major depression among elderly men. Psychiatry Clin Neurosci, 1998. 52(6): p. 577-9.

Furukawa, T., A. Yamada, H. Tabuse, K. Kawai, K. Takahashi, M. Nakanishi, and T. Hamanaka, Typus melancholicus in light of the five-factor model of personality. Eur Arch Psychiatry Clin Neurosci, 1998. 248(2): p. 64-9.

Furukawa, T., Depressive symptoms among international exchange students, and their predictors. Acta Psychiatr Scand, 1997. 96(4): p. 242-6.

Furukawa, T., Cultural distance and its relationship to psychological adjustment of international exchange students. Psychiatry Clin Neurosci, 1997. 51(3): p. 87-91.

Furukawa, T., Sojourner readjustment: mental health of international students after one year's foreign sojourn and its psychosocial correlates. J Nerv Ment Dis, 1997. 185(4): p. 263-8.

Furukawa, T., K. Anraku, T. Hiroe, K. Takahashi, T. Kitamura, T. Hirai, K. Takahashi, and M. Iida, Screening for depression among first-visit psychiatric patients: comparison of different scoring methods for the Center for Epidemiologic Studies Depression Scale using receiver operating characteristic analyses. Psychiatry Clin Neurosci, 1997. 51(2): p. 71-8.

Furukawa, T., T. Hirai, T. Kitamura, and K. Takahashi, Application of the Center for Epidemiologic Studies Depression Scale among first-visit psychiatric patients: a new approach to improve its performance. J Affect Disord, 1997. 46(1): p. 1-13.

Furukawa, T., M. Nakanishi, and T. Hamanaka, Typus melancholicus is not the premorbid personality trait of unipolar (endogenous) depression. Psychiatry Clin Neurosci, 1997. 51(4): p. 197-202.

Furukawa, T. and T. Shibayama, Intra-individual versus extra-individual components of social support. Psychol Med, 1997. 27(5): p. 1183-91.

Nakamura, H., M. Nakanishi, T. Hamanaka, S. Nakaaki, T. Furukawa, and T. Masui, Dissociations between reading responses and semantic priming effects in a dyslexic patient. Cortex, 1997. 33(4): p. 753-61.

Furukawa, T., M. Nakanishi, A. Sakurai, Y. Suzuki, A. Suzuki-Moore, and T. Hamanaka, Effects of ethyl loflazepate in mood and neurosis-related disorders (ICD-10 JCM): Changes in SCL-90-R subscale scores. Rinsho Seishinigaku (Clinical Psychiatry), 1996. 25(2): p. 233-240.

Furukawa, T., Factor structure of social support and its relationship to minor psychiatric disorders among Japanese adolescents. Int J Soc Psychiatry, 1995. 41(2): p. 88-102.

Furukawa, T., R. Awaji, H. Nakazato, and Y. Sumita, Predictive validity of subtypes of chronic affective disorders derived by cluster analysis. Acta Psychiatr Scand, 1995. 91(6): p. 379-85.

Furukawa, T., R. Awaji, H. Nakazato, and Y. Sumita, Persistence of chronic mood disorders: a 2 year follow-up. Psychiatry Clin Neurosci, 1995. 49(1): p. 19-24.

Furukawa, T., K. Takahashi, T. Kitamura, M. Okawa, H. Miyaoka, T. Hirai, H. Ueda, K. Sakamoto, K. Miki, and K. Fujita, The Comprehensive Assessment List for Affective Disorders (COALA): a polydiagnostic, comprehensive, and serial semistructured interview system for affective and related disorders. Acta Psychiatr Scand Suppl, 1995. 387: p. 1-36.

Furukawa, T., Weight changes and eating attitudes of Japanese adolescents under acculturative stresses: a prospective study. Int J Eat Disord, 1994. 15(1): p. 71-9.

Furukawa, T. and T. Shibayama, Factors influencing adjustment of high school students in an international exchange program. J Nerv Ment Dis, 1994. 182(12): p. 709-14.

Furukawa, T., H. Nakazato, and Y. Sumita, Characteristics of chronic outpatients with unipolar depression. Acta Psychiatr Scand, 1993. 88(4): p. 273-7.

Furukawa, T. and T. Shibayama, Predicting maladjustment of exchange students in different cultures: a prospective study. Soc Psychiatry Psychiatr Epidemiol, 1993. 28(3): p. 142-6.

Furukawa, T., Perceived parental rearing, personality and mental status in Japanese adolescents. J Adolesc, 1992. 15(3): p. 317-22.

Furukawa, T., Comprehensive Assessment List for Affective Disorders (COALA) (in Japanese)1992, Ichikawa: National Institute of Mental Health, National Center of Neurology and Psychiatry.

Furukawa, T. and Y. Sumita, A cluster-analytically derived subtyping of chronic affective disorders. Acta Psychiatr Scand, 1992. 85(3): p. 177-82.

Furukawa, T., Periodic psychosis associated with pseudo-pseudohypoparathyroidism. J Nerv Ment Dis, 1991. 179(10): p. 637-8.